Serotype Cross-Reactive CD8+ T Cell Response to Heterologous Secondary Dengue Virus Infections in Humans: a Dissertation by Bashyam, Hema Sundara
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Dissertations and Theses Graduate School of Biomedical Sciences 
2006-10-18 
Serotype Cross-Reactive CD8+ T Cell Response to Heterologous 
Secondary Dengue Virus Infections in Humans: a Dissertation 
Hema Sundara Bashyam 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss 
 Part of the Biological Factors Commons, Cells Commons, Hemic and Immune Systems Commons, 
and the Viruses Commons 
Repository Citation 
Bashyam HS. (2006). Serotype Cross-Reactive CD8+ T Cell Response to Heterologous Secondary Dengue 
Virus Infections in Humans: a Dissertation. GSBS Dissertations and Theses. https://doi.org/10.13028/
s0dv-7754. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/258 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and 
Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
SEROTYP : CROSS-REACTIVE CDS-I- T CELL RESPONSE TO
HETEROLOGOUS SECONDARY DENGUE VIRUS INFECTION IN HUMANS
A Dissertation Presented
HEMA SUNDARA BASHYAM
Submitted to the Faculty of the
University of Massachusetts Graduate School of Biomedical Sciences, \Vorcester
in partial fulfillment of the requirements for the degree of
DOCTOR OF PHILOSOPHY
IMMUNOLOGY AND VIROLOGY
OCTOBER 18, 2006
SEROTYPE CROSS-REACTIVE CD8+ T CELL RESPONSE TO
HETEROLOGOUS SECONDARY DENGUE VIRUS INFECTION IN HUMANS
A Dissertation Presented
By
HEMA SUNDARA BASHYAM
Approved as to style and content by:
Raymond M. Welsh, Ph.D., Chair of Committee
Leslie J. Berg, Ph.D., Member of Committee
Katherine Luzuriaga, M.D., Member of Committee
Madelyn Schmidt, Ph.D., Member of Committee
Christian Brander, Ph.D., Member of Committee
Alan L. Rothman, M.D., Thesis Advisor
Anthony Carruthers, Ph.D.,
Dean of the Graduate School of Biomedical Sciences
Program in Immunology and Virology
October 18, 2006
COPYRIGHT NOTICE
Parts of thIS dissertatIOIl have appeared in separate publications:
Bashyam HS, Green S, Rothman AL. 2006. Dengue virus-reactive CD8+ T cells display
quantitative and qualitative differences in their response to variant epitopes of
heterologous viral serotypes. J hnmunol. 176(5):2817-24,
Bashyam HS, Toyosaki-Maeda T, Stephens HAP, Mammen MP Jr, Kalayanarooj S
Libraty DH , Green S, Ennis FA, Rothman AL. 2006. Early and massive expansion of
dengue virus-specific CD8 T cells during acute secondary dengue infection in humans.
Manuscript submitted to the Journal ofhnmunology.
Bashyam HS, Zivny J, Zivna Rothman AL. 2006. Diversity of Dengue-Specific Human
CD8+ T cell Clonal Response to Natural Epitope Varants. Manuscript in preparation.
ACKNOWLEDGEMENTS
There are several people who I want to thank for preparing me for a career in
scientific research. Foremost on this list is my thesis advisor Dr. Alan Rothman, who , in
addition to being a truly gifted scientist, is a devoted mentor, an engaging teacher, an
exacting critic , and an inspirational (and sometimes daunting) role model. I have learned
from him that there is no substitute for a well-planned and structured 'approach in testing
a hypothesis , no comparable alternative to being well-grounded in published literature
and that there is incalculable value in thinking about data analyzed long ago , and then
thinking about it some more. I am paricularly grateful for his abundant patience, and for
his willngness to allow me (undeserved) freedom in my day-to-day labors in the lab. I
can say with confidence that Alan is the nicest mentor that I will ever have worked with.
I was incredibly lucky in training in an environment so well-stocked with
scientists with diverse interests and expertise in their fields. It was a pleasure to
paricipate in our mammoth lab meetings and learn from the discussions. I am deeply
grateful to Drs. Sharone Green and Anuj a Mathew for all their help and encouragement
and to Dr. Tomoko Maeda for bequeathing to me the tetramer clinical study project.
My thesis which was so heavily dependent on FACS would have gone nowhere if
not for Marcia W oda who was incredibly generous with her time and prodigiously
forgiving of such transgressions as sending up too many spontaneously set-up
experiments.
I am especially thankful to Dr. Ennis for his sage advice and insights regarding
my thesis and his bon mots regarding everything else.
It was an honor to have Drs. Ray Welsh, Leslie Berg, and Katherine Luzuriaga on
my thesis advisory committee. Their comments and questions greatly enhanced and
improved my work and I thank them for their time.
I also want to thank the dengue patients and vaccinees who contributed samples to
my studies.
My life would have been devastatingly lonely but for the following people who
indulged me with copious amounts of affection and good-will. So a colossal thank you to
my pals and family members for making me a part of their lives and in particular, for
good-naturedly listening to my every woe (Mary Co , Diego Farfan), plying me with good
food (for the mind as weUas the ' dy - the Kaushiks and the Dutta Rays), engaging me
in highly entertaining arguments (Alex Chen, Rajas Warke), sheltering me during my
hegiras from lab (Heather van Epps, my cousin Perry and his family), and fortifying me
with encouragement from afar (my cousins Girish Srila, and Karthik).
I did' nt see my family in India much during these years. But my bouts of home-
sickness were infrequent and transient, thanks to Andrea Wright and Peggy Anderson
who virtually adopted me into their household and gave me all the love and support that I
could ever need.
My family in India has waned in number during the last several years. My
beloved uncle, aunt, and grandparents who are no more always wished the best for me
and I will forever miss them.
While some of the best things about the past several years are as described above
the worst aspect of this time was being away from my parents. But they have been with
me in spirit on every step of my journey through graduate school and are entirely
responsible for any and all success that has come my way. They are my conscience; they
are my world.
THESIS ABSTRACT
The generation of memory T cells following primary exposure to a pathogen is a
critical feature of the vertebrate immune system which has evolved as a protective
mechanism in order to defend the host agaInst repeated assaults by the pamogen. lVIemory
T cells are long-lived , undergo rapid proliferation upon re-activation, mediate a robust
secondary response and clear the pathogen much more efficiently. These aspects have
made the generation of memory T cells an attractive goal for the production of both
prophylactic and therapeutic vaccines. However, the degeneracy of the T cell receptor
whereby a given T cell recognizes more than one epitope, allows the T cell to be
modulated by epitope variants which could be self-ligands , ligands related to the original
epitope but altered in sequence, or completely unrelated epitopes. Experiments in both
mice and humans show that such cross-reactive stimulation of memory T cells results in
complete, partial , or no activation ofT cells , and in some cases, even alters the functional
identity ofthe T cell (for example, T helper 1 cells start secreting IL- , IL-5 and become
par of a T helper 2 response). In the context of secondary infection of immune organisms
with pathogens containing mutated or related T cell epitopes, such alterations at the
cellular level translate into drastic changes in the overall clinical outcome of the
infection. Thus, the presence of cross-reactive T cells in the memory population implies
that the protective or pathologic nature of the secondary immune response is a
consequence of the host' s infection history. Although several murine models of
heterologous infection resulting in altered pathological outcome have been studied, the
exact immune correlates of protection versus immunopathology are stil unclear. This
thesis addresses this issue in dengue virus infections in humans.
VII
Denguefevet (DF) and Dengue Hemorrhagic Fever (DHF) are two disease
manifestations caused by infections of humans by the dengue viruses. These are a group
of 4 serologically distinct flaviviruses (D 1-4) which often co-circulate among endemic
. populations. While primary infection with any of the four serotypes can result in the more
severe clinical disease characterized by DHF, epidemiological data from several
outbreaks show that 80% - 90% of DHF cases occur among individuals with secondary
infection. This implies that prior immunity to dengue is actually a risk factor for
developing severe disease. In these DHF cases, there are increased numbers of CD69
CD8+ T cells in circulation, with increases observed in the frequency of epitope-specific
T cells , and the serum levels of several T cell produced cytokines
, '
chemokines , and
immune receptors are highly elevated. Since the four serotypes share 65% - 75% amino
acid sequence homology, the possibility that unconserved T cell epitope sequences
stimulated cross-r:eactive responses was borne out in in vitro examinations. In these
studies, peripheral blood mononuclear cells (PBMC) and cloned T cells from both
vaccinated and infected donors contained lar e populations of memory T cells that were
cross-reacti for heterologous viral serotyPes in proliferation and CTL assays. These
data suggest that the severity of disease seen in DHF patients can be attributed to an
immunopathologic secondary response during heterologous infection, and highlight a role
for serotype cross-reactive T cells in this process.
This thesis addresses the hypothesis that the recognition of the natural variants of
dengue virus T cell epitopes by serotype cross-reactive CD8+ T cells of a dengue-immune
donor results in an altered secondary response profile, with the changes reflected in both
the quantitative and qualitative nature ofthe response. In order to compare the functional
Vll
profile of the secondary response of dengue-immune PBMC re-activated with.
heterologous serotypes, we focused on a panel of 4 donors who were. vaccinated with live
attenuatedmonovalent vaccines corresponding toDl , D2 , or D4 serotypes. We screened
a panel of pep tides predicted to bind to HLA-A*0201 for cytokineresponses and
identified 4 novel epitopes that were highly immunogenic in all four donors. Direct 
vivo stimulation of donor PBMC with the heterologous sequences of these epitopes also
showed sizeable serotype cross-reactive T cell populations. CFSE- and intracellular
staining for cytokines and chemokines showed that these cross-reactive T cells not only
expanded but also produced IFNy, TNFa, and MIP- l;6. Multi-parameter staining revealed
functionally diverse populations comprised of single cytokine (IFNy , TNFat, MIP- l(t),
double cytokine (IFNy TNFct, IFNy MIP- l(t, TNFclMIP- l(t), and triple cytokine
(IFy TNFatMIP- l(t) secreting sub-sets. Stimulation with the epitope variants altered
the magnitude of the overall response as well as the relative sizes ofthese sub-sets. The
patterns of responses revealed the effects of epitope immunogenicity, infection history
and donor-specific variability. All 4 donors showed the highest cytokine response to a
single epitope (NS4b 2353). The same two peptide variants (D2 NS4a 2148 and D3 NS4b
2343) induced the highest response in all 4 donors regardless of the serotype of primary
dengue infection. Interestingly, the epitope variants which showed the highest
immunogenecity in our donors corresponded to the D2 and D3 serotypes which have
been documented as being more virulent as well as a viral risk factor for DHF. In one
donor, the response to all peptide variants was dominated by the same cytokine sub-sets.
These data suggested that the dengue-immune memory T cell repertoire was functionally
diverse and underwent alterations in size after secondary stimulation. Therefore, we also.
investigated the effect of epifojJe viariants on .dengue specific CD8+ T cell clones isolated
from vaccinated and infected donors in order to determine if epitope variants induced
altered' functiomil outcomes' auhe clonaUeveL The epitope variants functioned either 
strong agonists (particularly the D2 and D3 sequences); partial agonists , or nullligands.
Some variants were able to induce cytolysis but not other effector functions at low
concentrations. The variant ligands also influenced the hierarchy of cytokine responses
within each done. .
The third part of this thesis focused on the characterization ofthe frequency and
phenotypic profile of epitope-'specific CD8 + T cells in patients with DHF and DF at
different times in the disease course in order to better understand the kinetics of the
response and delineate any differences between the immune profie of severe vs.
moderate disease. Tetramer staining for a previously identified HLA-B*07 restricted
epitope was combined with staining for activation markers (CD69, CD38 , HLA-DR),
homing receptors (CCR7 CD62L), and programmed death receptor 1 (PD- l). The DHF
subjects had early T cell activation with higher frequencies oftetramer CD69+ cells as
compared to DF subjects , in whom T cell frequencies peaked around the time of
defervescence. While each subject had a unique phenotypic profie oftetramer+ cells
there was a difference between DF and DHF subjects in terms of CCR 7 expression; all
subjects expressed low levels ofCCR7 during acute illness but only the DHF subjects did
not show upregulation ofCCR7 on tetramer+ cells during convalescence. These data
suggest that there is a sustained alteration in memory phenotype in those who recovered
from severe dengue disease. A majority of the tetramer+ cells also expressed PD- l during
acute ilness but not during convalescence. Double-staining with varant tetramers
allowed us to directly visualize serotype cross-reactivity of the epitope-specifi
populati , and showed that secondary stimulation did induce the expansion of cells with
.low avidityfor'hat secondary serotype 
and higher avidity to the variant. Furthermore, the
ratios of these sub-sets changed during the course of the response.
. Taken together, these studies suggest that the immune response to heterologous
secondary dengue infection is mediated by a heterogeneous population of serotype-cross
reactive T cells. that have different functional avidities to epitope variants 
and is
influenced by the serotype of the secondary infection as well as the prior infection history
of the individual. The preferential expansion of clones which secrete IFNy but not
inflammatory MIP- l(3 or TNFa or a repertoire characterized by a higher ratio of cytolytic
to cytokine producing clones could limit immune mediated damage while 
effciently
clearing the virus. This information wil be useful in the design of vaccine strategies
aimed at inducing protective cross-reactive responses against all 4 dengue serotypes
while preventing immunopathological outcomes following secondary infection.
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CHAPTER I
INTRODUCTION.
Dengue is an arthropod-borne viral illness which threatens about 2. 5 billion
people worldwide. About 50 to 100 million people each year are estimated to suffer from
dengue fever (DF) or the more severe and potentially fatal dengue hemorrhagic fever
(DHF) and dengue shock syndrome (DSS) (Gubler, 1997). These illnesses are caused by
a group of 4 antigenically related viruses referred to as dengue serotypes 1-4 (Sabin
1952). Infection with one serotype provides life-long immunity to re-infection by only
that serotype but not the others , and sequential infection with a heterologous dengue
serotype frequently results in DHF/DSS. Hence inhabitants of those areas where dengue
is endemic and where multiple serotypes are in co-circulation are susceptible to multiple
infections over their life-time and are at risk for developing severe dengue disease.
Dengue infections are one of the biggest public health problems in tropical areas such as
South/South-East Asia, South America, the Caribbean countres, and Afrca (Halstead
2002). In the United States, dengue outbreaks have been reported since the 1980s in
communities along the D. Mexico border and also in Hawaii in 2001-2002 (MMWR,
2001; Effer et aI. , 2005). The mosquito vector of dengue Aedes aegypti - is widely
found in the Southern States and around 4000 cases of imported dengue have been
reported in the last 3 decades (CDC, 2006).
There is currently no licensed vaccine against dengue. The lack of success in this
conventional solution to the problem can be partly attributed to the lack of appropriate
animal experimental models and the necessity of inducing protective immunity against all
four dengue serotypes while avoiding potentially harful virus-specific immune
responses. Aside from studies aimed at designing and clinically testing dengue vaccine
candidates , a major focus of dengue research is to understand why secondary dengue
infections cause severe disease and how the mechanisms of secondary immune response
may cause immunopathology as opposed to offeringprotective immunity.
Based on earlier research, our group had hypothesized that the re-activation of
memory serotype cross-reactive Tcells during secondary dengue infection and their
suboptimal activation by the epitope variants of the heterologous serotype contributed to
the enhanced immunopathology seen in DHF. The goal of this thesis was to test this
hypothesis by studying the breadth and patterns of functional heterogeneity among
serotype cross-reactive CD8+ T cell subsets. \Ve identified novel T cell epitopes restrcted
by the commonly found class I HLA-A *02 allele which is associated with high risk for
DHF, by screening PBMC from immunized individuals and studying the functional
cross-reactivity of dengue virus-specific T cells at bulk and clonal levels. We also
attempted to understand the kineticsofthememory response and the differentiation of
dengue-specific T cells during the acute and convalescent stages of viral infection by
tracking tetramer+ T cells in PBMC samples from dengue-infected patients.
This Introduction is divided into sections that pertain to various aspects of this
thesis. An overview of the viral genome and polyprotein is followed by sections covering
clinical descriptions of dengue disease, DHF risk factors, dengue-specific immune
responses, and evidence ofDHF immunopathology. The next sections are specifically
devoted to the discussion of serotype-cross-reactive T cells, their contributions to the
phenomenon of heterologous immunity, and the biological implications of their
l__
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activation by altered peptide ligands. The final sections include an overview of CDS+ T
cell differentiation during acute viral infectiol1and a description of various T cell
memory subsets as characterized by phenotypic and functional markers.
A. DENGUE VIRUS - GENOME, STRUCTURE, AND LIFE CYCLE.
Dengue is a member of the Flaviviridae family and belongs to the Flavivirus
genus in which there are more than 70 viruses including yellow fever virus (YFV), West
Nile virus (WN) and Japanese encephalitis virus (JEV). The dengue virion is composed
of a single, positive-sense -llkb RNA genome packaged by a viral capsid (C) protein
and enclosed within a host-derived lipid bilayer studded with two viral structural proteins
- the envelope (E) protein and the membrane (M) protein. Seven other non-structural
proteins are encoded by the genome, and these are designated as NS 1 , NS2A, NS2B
NS3 , NS4A, NS4B , and NS5. The genome is translated as a single open reading frame.
The polyprotein is processed by a host enzyme to yield the pre-M, E, and NS 1 proteins
and the rest of non-structural proteins are produced as a result of cleavage by the viral
'protease encoded by NS3 (reviewed in Lindenbach , 2001).
Dengue virus enters the host cell by receptor-mediated endocytosis. Proteins such
as DC-SIGN, GRP78 , and CD 14-associated molecules have been proposed as the host
cell receptors (Lozach, et aI. , 2005; Tassaneetrithep, et aI. , 2003; Jindadamrongwech, et
aI. , 2004; Chen, et aI. , 1999), while glycosaminoglycans such as heparan sulfate have
been suggested as low-affnity co-receptors (Chen, et aI. , 1997). Fusion of the virion and
the host cell is followed by the release of the nucleocapsid into the cytoplasm
dissociation of the RNA genome from the capsid protein, initiation of translation and
replication of the viral genome, followed by virion assembly (reviewed in.
Mukhopadhyay, et aI. , 2005). Work done on tick-borne encephalitis (TBE) virus shows
that the structural genes C , pre- , andE which are at the 5' end of the genome , are the
first to be synthesizedatthe ER surface. A signal sequence at the carboxyl terminus of
the C protein allows the pre.;M and E to be translocated into the ER lumen, undergo late
cleavage by furin proteinase to form mature M and E proteins (Lorenz, et al. 2002). This
step is crucial for the formation of fully infectious virion particles since virions
containing uncleaved prM have low infectivity (Randolph, et aI. 1990).
The E protein is essential for receptor binding and membrane fusion, since it
contains several receptor binding sites and encodes a fusion peptide (Lorenz, et aI. , 2002;
Allson, et aI. , 2001). This protein also contains an assortment of epitopes for neutralizing
and non-neutralizing antibodies. Mutations at these epitopes have been shown to affect
viral infectivity and pathogenesis (Monath, et'al. , 2002). An aray of monoclonal
antibodies (mAbs) against E protein epitopes have been developed and tested for their
protective efficacy (reviewed in Roehrg, et aI. , 2001). Non-neutralizing mAbs and
neutralizing mAbs at sub-neutralizing concentrations have been shown to enhance the
infection of susceptible cells via a process known as antibody dependent enhancement
(ADE) (reviewed in Morens , 1994). This is an in vitro phenonmenon in which the
infection of cells such as monocytes and macrophages which bear Fc gamma receptors is
modified by the addition of virus-reactive antibodies at certain concentrations.
The 7 non-structural genes, which represent two-thirds of the dengue genome, are
found at the 3' end. The NS proteins are generally more conserved among the dengue
serotypes and other flaviviruses. The NS2a and the NS3 proteins have proteolytic
activity. NS2a mediates cleavage,\between NS 1 and NS2b. The NS 1 protein has
complement fixing activity and can exist in ceH-associated cell-surface, or secreted
forms (Lee, et aI. , 1989). Two recent studies in dengue patients showed that high levels
of circulating NS 1 correlate with high viral titers , complement activation and increased
disease severity, and the ability ofNSl to mediate complement activation has been
proposed to contribute to vascular leakage in DHF and DSS (Libraty, et aI. , 2002;
A virutnan, et aI. , 2006).
The NS3 protein is the second largest and most highly conserved of the dengue
virus proteins and is a multi-functional enzyme. It has N.,termnal sequence homology to
trysin-related serine proteases and C-terminalhomology to RNA helicases and is
involved in viral RNA replication and capping (Bazan and Fletterick, 1989; Benarroch, et
aI. , 2004). The NS4a and NS4b proteins are hydrophobic proteins and have both been
shown to contribute to the inhibition of interferon signaling and IFNJ3-stimulated gene
expression (Munoz-Jordan, et aI. , 2005). TheNS5protein is the largest dengue protein
and is an RNA dependent RNA polymerase. Its N-terminal portion includes a
methyltransferase core and a nearby GTP-binding site, which enable this protein to
mediate RNA capping (Engloff, et aI. , 2002). An additional role for this protein has been
revealed in a recent study which showed that the expression ofNS5 in HEK-293 cells
induces IL- , a chemokine found at high levels in sera from patients with severe dengue
disease (Medin, et aI. , 2005).
B. CLINICAL MANIFEST A TIONS OF DENGUE DISEASE.
A majority of primary dengue virus infections results in asymptomatic infections.
Clinical dengue disease ranges from a relatively mild DF to the potentially fatal
hemorrhagic disease DHFand its 'most severeform, DSS (Burke, et aI.
, 1988
Nimmanitya, 19,87). DF is an acute, self-limited, febrile illness characterized by fever
malaise, muscle aches , headache, nausea, and vomiting which lasts for about 5-
7 days
and can occur after infeCtion with any of the four dengueserotypes. Patients 
with these
symptoms sometimes also have a macular or maculopapular rash. Other characteristics of
the disease include neutropenia, leucopenia, thrombocytopenia, and the presence of
atypical lymphocytes. Most patients recover from DF.
In about 5-30% of cases, these symptoms are followed by the development of
increased capillary permeability and vascular leakage during the time of defervescence
which are characteristic ofDHF. According to guidelines established by the 
WHO, the
clinical definition ofDHF includes fever, a positive tourniquet test, hepatomegaly,
hemoconcentration (::20% increase in hematocrit), and thrombocytopenia
(":100,OOO/mm\ These minimal criteria are classified either as grade 1 DHF or
, if
spontaneous bleeding is also present, as grade 2 DHF. Grades 3 and 4 DHF
, in which
shock develops , are defined as DSS. As many as 95% ofDHF/DSS patients (in South
East Asia) are children under the age of 15. Most patients recover from these symptoms
following fluid replacement therapy. However 50% ofDSS cases wil result in
mortality in the absence of treatment (Guzman and Kour, 2002). Severe gastrointestinal
bleeding and hepatic failure can be direct causes of death.
C. RISK FACTORS FOR DHF.
1. Viral factors:
';'
While it is known that thete are genetic differences between the various strains 
dengue virus, the difference.in virulence and itsimpact on clinical disease was
highlighted by the Cuban epidemic of 19S1. Although several dengue viral strains from
the American genotype of D2V were found to. be inco.,circulation in South American
countries by the SOs , the occurrence ofDHFcases during the epidemic coincided with the
appearance ofthe Asian genotype ofD2V (Rico-Hesse, 1990). This notion ofstrain-
dependent virulence as a DHF risk factor has been borne out by other epidemiological
findings from outbreaks in Peru and Sri Lanka. These studies showed that the presence of
DHF cases was not associated with the American D2V g notype, and coincided with
circulation of the more virulent Asian D2V genotype (Watts , et aI. , 1999; Messer et aI.
2002). Another study which examined the relationship between dengue disease and
circulating serotypes in Bangkok found that, although yearly epidemics were associated
with different serotypes, the years with seVere outbreaks were solely associated with the
D3 serotype (Nislalak, et aI. , 2003).
Other studies have tried to pinpoint the specific molecular determinants of
virulence. These investigations were carred out in vitro in cloned or cell-culture
passaged wild or attenuated viruses. Sequence changes that altered virulence were shown
to map to regions in the prM, E, NS 1 , and NS3 genes and also to the 5' and 3' non-
translated regions (NTRs) (Kinney, et aI. , 1997; Mangada, et aI. , 1997 , Mangada, et aI.
1995).
2. Host factors:
The factors which may contrbute to predisposing an individual to severe dengue
disease include sex, race, nutrtional status, immune status (occurrence of chronic
infections), and age. Epidemiological surveys of Thai and other South East Asian
epidemics have sho\\'l tha1 children under 1 year and those between 3 - 5 years of age
. are at higher risk for DHF (Nimmanitya, 1987). Genetic polyrorphisms have also been
shown to influence susceptibility to DHF.. A mutation leading to the change of a single
amino acid in the FcyR IIA receptor is believed to reduce antibody-dependent
enhancement of infection by decreasing the level of opsonization by IgG2 antibodies and
thus offers protection from DHF (Loke, et ai, 2002). Similarly, certain variants ofthe
vitamin D receptor associated with a stronger T helper response and a variant in the DC-
SIGN promoter CD209 thought to result in lower transcription and expression levels of
the receptor are associated with decreased risk of severe disease and protective immunity
(Loke, et aI. , 2002; Sakuntabhai , et aI. , 2005).
Several groups have also proposed HLA haplotype as a determinant of disease
outcome. The earliest study carred out on Thai subjects in the 80s showed an increased
frequency ofHLA-A*02 among DHF patients (Chiewsilp, et aI. , 1981). Recently, Loke
et ai, showed that susceptibility to DHFamong Vietnamese subjects was significantly
associated with polymorphism at the HLA-A locus , and that the HLA-A *33 allele was
associated with a reduced risk of developing DHF (Loke, et 'aI. , 2001). Another study
compared HLA class I allele profies of Thai subjects both atthe phenotypic and
molecular level and found that HLA-A *0203 was associated with less severe DF
regardless ofthe secondary infection serotype while HLA-A *0207 was associated with
the more severe DHF in patients with secondary Dl or D2 only (Stephens , et aI. , 2002).
That study also looked at HLA-B alleles and identified HLA-B44 , B62 , B76, and B77 as
alleles that appeared to protect against clinical disease following secondary infection
~~~,. "
. while showing an associationofHLA-B51withsevere DHFarid HLA-
B52 with DF.
These findings imply that the presentation of CD8 T cell epitopes by the disease
susceptible alleles is ,a risk factor for DHF and this must therefore be taken into
consideration during the design of vaccines to provide protective iniunity. Finally, the
previous infection history of the host may also predispose him or her to severe DHF via
the action of pre-existing dengue-specific antibodies and serotype cross-reactive dengue-
specific T cells. The mechanism of action and immunopathological contributions of both
these immune response components will be explained in the following sections.
3. Se uential den ue infections:
A minority of DHF cases occur as a result of primary infections paricularly in
infants 6-12 months of age whose mothers had two or more previous dengue infections
(Kliks, et aI. , 1988). These infants showed DHF/DSS symptoms only during the time
when maternal antibodies had degraded to titers where they were no longer neutralizing
virus but enhancing infection. Supporting this idea; that infants only became vulnerable
to severe disease during the particular time-frame when maternal antibodies were no
longer protective, another study found that infants under 3 months of age were in fact
symptom-free despite being seropositive for dengue infection (Halstead, et aI. , 2002).
This study also found that there were very few DHF/DSS cases among children older
than 1 year and younger than 4. In these children, maternal antibodies had been
completely degraded to concentrations below that required to enhance infection.
However, early studies of dengue epidemics in Thailand in the 80s found that
DHF and DSS were 15-80 times more likely to occur following secondar dengue
infections than primary infections:'\Halstead, etal. 1982; Sangkawibha, etaI. , 1984).
Similar findings were reported by another group which studied an epidemic caused by
D2V in Cuba in 1981 following a primary Dl V epidemic in 1977 (Guzman : et aI. , 1987;
Bravo , et al. 1987; Guzman, et aI. , 1991), While children between 1-3 years of age who
had not been previously exposed to Dl V developed DF most ofthe DHF cases occurred
in those patients older than 4 years who had previously had a primary D 1 V infection.
These studies , along with Halstead et ai' s observation that the Thai secondaryDHF cases
showed dengue-specific antibodies, supported the hypothesis that the immune response to
the secondary infection played a role in the pathogenesis ofDHF. It is now accepted that
antibody-dependent enhancement mediated by cross-reactive sub-neutralizing antibodies
and the immune response mediated by serotype cross-reactive T cells are two
mechanisms by which secondar dengue viral infection could res lt in severe disease.
D. IMMUNE RESPONSES TO DENGUE VIRUS.
The host response to dengue virus infection involves a rapid induction of innate
immune mechanisms followed by humoral as well as T cell mediated immune responses.
1. Inate immunity:
The infection of immature dendritic cells (DCs) via the DC-SIGN receptor
induces the production of anti-viral cytokines such as type-I interferons and (3, and
TNF-a, (Libraty, et aI. , 2001; Palmer, et aI. , 2005). The early release ofthe type I
interferons as well as IFNy is crucial in mediating resistance to DV infection; mice
deficient in type-I interferon receptors do not survive intraperitoneal inoculation ofDV
(Shresta, et aI. , 2004; Johnson et aI. , 1999). DV-stimulated DCs upregulate the expression
of maturation markers such asHI:A- CD83 , andCDHb. Several studies; however
show that they differentiate into functionally impaired antigen-presenting cells which
secrete IL- l 0 and are unable to effciently activate T cells (Mathew et aI. , 1999;, Palmer
et al.; 2005). Considered along with the previously discussed ability ofDV to suppress
type- I interferon signaling, these findings highlights the ability of DV. to evade innate
immune mechanisms. Another aspect of the early response against DV infection is the
activation ofNK cells which can clear infected cells by direct cytolysis or antibody-
dependent cell cytotoxicity (ADCC). While information on the importance ofNK cell
activity in human infections is limited, studies in mice have shown that NK cell activity
may be important for clearing primary DV infection (Shresta, et aI. , 2004).
2. Antibody-mediated immunity:
The dengue virus E protein is the predominant target of antibodies that can
prevent viral binding and fusion and neutralize viral infectivity in vitro (Roehrg, et aI.
1998). Another target of the antibody response is the NS 1 protein, which is present as
both cell surface and secreted forms. Anti-NSI antibodies can fix complement and
mediate the lysis of dengue-infected cells. In vivo evidence of antibody-mediated
protection against dengue infection comes from studies where passively transferred
antibodies against the E , prM , and NS 1 proteins protected mice against lethal infection
(Kaufman, et aI. , 1987; Kaufman, et aI. , 1989; Schlesinger, et aI. , 1987). In humans
however, anti-NSI antibodies (against amino acids 1- 15) have been shown to have
detrimental effects due to their cross-reactivity with endothelial cell surface antigens
thereby inducing nitric-oxide (NO) mediated apoptosis, which is a possible cause for the
vascular damage seen in DHF/DSS patients (Lin, et aI. , 2003).
Another study that highlighted the pathologic effect of the antibody response was
published by Endy et al. Pre-secondary infection plasma obtained from dengue-immune
chiidren contained serotype-cross-reactive antibodies which seemed to protect against
disease severity following secondary D3infection but not secondary D 1- or D2 infections
(Endy, et aI. , 2004). However, the downside, to inducing antibody responses is of course
ADE , which occurs when antibodies present at sub-neutralizing concentrations and those
generated against non-neutralizing epitopes enhance viral uptake into FcRII bearng cells.
Pre-existing antibodies thereby increase the viral load, which in some instances has
coincided with disease severity (Littaua, et aI. , 1990; Vaughn, et aI., 2000; Kliks , et aI.
1989).
3. T cell-mediated immunity:
The CD4+ and CD8+ T cell response to DV is directed primarly against non-
strctural proteins with the immunogenic NS3 protein containing most of the epitopes
identified to date (Lobigs , et aI. , 1994; Mathew, etal. , 1996). Following their interaction
with DV -infected antigen presenting cells, DV -specific T cells are activated to
proliferate , produce high levels ofIFNy, TNFa, TNFfJ, and MIP- lfJ, and lyse DV-
infected targets via perforin and granyme mediated mechanisms (Rothman, 2003). Both
serotype-specific and serotype-cross-reactive memory T cells have been detected in
dengue-immune PBMC following primary infection (Kurane, et aI. , 1989). While earlier
studies showed that the highest T cell responses against whole dengue antigen or virus
were against the primary infecting serotype, more recent studies have shown that the
level and pattern of cross-reactivity depend on the extent of homology between the
epitope sequences among the fouFserotyPes. Analysis of cross-reactive responses at the
clonal level shows that thesedifferentes, in sequence might have functional
consequences. For example, a CD8+ T cell clone has been shown to have partial agonist
responses against a variant epitope sequence from a heterologous serotype by lysing
target cells while being unable to proliferate or produce cytokines (Zivny, et aI. , 1999).
Other examples of altered immune responses following heterologous secondary
infection have been reported in studies which examinedepitope-specific T cell
frequencies in dengue-infected patients using HLA tetramers bound to variant epitopes
(Mongkolsapaya, et aI. , 2003; Mongkolsapaya, et aI. , 2006). In patients with severe
disease, frequencies of CD8+ T cells specific for the known secondar serotype were
lower than the frequencies of cells specific for presumably previously encountered
heterologous serotypes.
In terms of responses on a larger scale in vitro activation by whole dengue
antigen resulted in higher frequencies ofIFNy+ CD4+ T cells in response to homologous
stimulation while stimulation with heterologous antigens resulted in a higher ration of
JNFa: IFNy producing cells (Mangada, et aI. , 2005). In a clinical study which examined
cytokine responses to all 4 serotypes in PBMC from dengue-immune individuals prior to
their secondary infections , a broadly serotype-cross-reactive IFNy response was weakly
associated with the occurrence of mild disease (Mangada, et aI. , 2002). While there
remains uncertainty as to how T cell mediated responses specifically contribute to
protective immunity, the findings ofthese two studies seem to suggest that paricular T
cell functions performed by a subset of cells among the heterogeneous dengue-specific
population could potentially result in a beneficial outcome.
E. IMMUNOPATHOLOGICAIZ MECHANISMS INDHF;,
1. Evidence of immune-mediated cellular damage:
The capillary permeability and vascular leakage seen in DHF patients occurs at
the time of defervescence following viral clearance, is reversible, and does not result in
permanent organ failure. This suggests that the damage is not due to cytopathic effects of
the virus itself. In lieu of animal models that faithfullyreproduce the characteristics of
human dengue virus infection, investigators have used human endothelial cell lines
infected in vitro to track the mechanisms that lead to vascular permeability. Upon DV
infection, these cell lines produce pro-inflammatory cytokines such as IL- , IL- , and
RANTES , undergo changes in their actin cytoskeleton, and show increased permeability
to small molecules (Peyrefitte, et aI. , 2006; Talavera, et aI. , 2004). Treatment of
endothelial cells with dengue-immune sera from patients with acute infection activates
them and renders them vulnerable to apoptosis (Cardier, et aI. , 2005). However, the
addition ofanti-TNFamonoclonal antibodies can partially reverse these effects
indicating a role for this cytokine in initiating plasma leakage.
Liver injury as indicated by elevated serum levels of liver enzymes , and detection
of viral antigen in liver hepatocytes in a small number of cases are other characteristics of
DHF (Kuo , et aI. , 1992; Couvelard, et aI. , 1999). HepG2 cells infected in vitro with DV
produc various inflammatory cytokines and chemokines and undergo TRAIL-mediated
apoptosis (Matsuda, et aI. , 2005). Further evidence of immunopathology was seen in
immunocompetent D2V -infected mice in which the kinetics ofliver enzyme elevation
correlated with the kinetics of cellular infiltration and T cell activation (Chen, et aI.
2004). In D3V infected Thai subjects , liver enzyme levels correlated with plasma levels
of soluble IL-2 -receptor, which is !an indicator of T cell activation and proliferation
(Libraty, et aI. , 2002). This suggests that liver injury may be a result ofT cell activation.
2. Evidence for Tcell-mediated pathol
The epidemiological data which ,show increased occurrence ofDHF after
secondary dengue infections and the detection of serotype cross-reactive Tcells in patient
PBMC following primary infections suggest a role for memory T cells in DHF
immunopathology. Elevated levels ofT cell-'produced cytokines such as IFNy, TNFa, IL-
, IL- l 0, and other cytokines such as IL-S are seen during acute dengue infection even
before the onset of plasma leakage (Kurane, et aI. , 1991). A higher level of immune
activation is seen in DHF cases as compared to subjects with mild disease as shown by
studies in which elevated levels of soluble TNF receptors, soluble IL-2 receptor, and
soluble CDS correlated with disease severity (Green, et aI. , 1999). Other observations in
DHF subjects include an earlier and increased expression of CD69 both on NK cells and
CD8+ T cells (Green, et aI. , 1999), and earlier peak levels ofIFNy as compared to that
seen in DF cases (Libraty, et aI. , 2002). High levels ofTNa have also been associated
with disease severity (Hober, et aI. , 1993; Mangada, et aI. , 2003).
The increased immune activation in DHF is accompanied by an overall decrease
in the sizes of lymphocyte subsets, including CD4+ and CD8+ T cells, NK cells , and yo T
cells (Green, et aI. , 1999). It is possible that DV infection results in the apoptosis of
PBMC via Fas signaling; alternately, the cells may be undergoing activation-induced cell
death following their interaction with functionally impaired DV -infected APCs (Myint, et
aI. , 2006; Mathew et aI. , 1999).
-"- ' - -''"-
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In more recent studies which examined epitope-specific T cell responses, higher
frequencies- of epitope-specifc TceUs correlated with severe disease (Zivna, et aI. , 2002;
Mongkolsapaya, et al. 2003; Mongkolsapaya, etal. , 2006). While Zivna et al used
ELISPOT assay to track HLA-B*07 restricted epitope-specific responses , the latter
studies used HLA tetramers to identify T cells specific for an HLA-A *11 restricted
epitope.
Based on these findings, our group initially proposed a model for DHF
immunopathology in which serotype cross-reactive T cells generated during the immune
response to the primary infection were preferentially expanded early during the
secondary immune response to a heterologous serotype. The partial activation of these
cells by variant heterologous T cell epitopes could produce an enhanced proinflamatory
response while only providing a suboptimal antiviral effect, thereby resulting in poor
viral clearance and severe disease outcomes (Kurane, et aI. , 1994; Zivny, et aI. , 1999).
We have since attempted to further characterize the specific nature of this altered
secondary immune response by examining an array of in vitro T cell functions following
heterologous stimulation.
Mongkolsapaya et al approached this issue by examining the avidities of dengue-
specific T cells to ,epitope varants from the secondary serotype vs heterologous serotypes
in PBMC from patients with acute dengue infection. They found that serotype cross-
reactive T cells had a low avidity for the secondar serotype while higher frequencies of
cells were specific for the heterologous serotype. These low affnity memory T cells were
thought to dominate the secondary immune response because of their higher precursor
frequencies or alternatively due to the death of high affnity T cells by apoptosis
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Figure 1: Model of ' ori inal anti enic sin ' and its im act on DHF immuno atholo
The naive T cell repertoire is composed of clones which are heterogeneous in their affnities for
DV epitopes. (a) Priar infection with D2V or D3V induces the expansion of the clones that
have highest affinity for that serotype and the imunodominance of this population is reflected in
the memory pool that is established. (b) Secondar infection of a D2 imune subject by D3V
may be followed by the preferential expansion of the memory population that had higher affnity
for D2 as opposed to naive cells that wil be pried by D3V. An additional or alternative
mechansm may be the deletion ofD3Vhigh-affinity cells due to activation-induced cell death
(AICD). Under either circumstance, the result is a T cell repertoire that is composed of cells that
have low avidity to the secondary serotype. This situation may lead to ineffcient lysis of infected
cells and enhanced secretion of inflamatory cytokies and thereby result in DHF.
following antigenic stimulation. This phenomenon of ' originalantigeilic sin? ,was
proposed to contribute to DHF immunopathology by preventing the efficient clearance of
the currently infecting serotype due to the low affnity of the T cells for the viral variant
while stil maintaining an output of proinflammatorycytokines and chetnokines (Figure
1).
These findings altogether imply that (i) the outcome of secondary dengue
infection in an individual is influenced by the history of previous dengue infections in
that individual, (ii) the modification ofthe dengue-specific serotype cross-reactive
memory T cell repertoire by secondary infection may lead to enhanced immune response
due to low viral clearance and high antigen load, and (iii) there is a qualitatively altered
immune response following stimulation by variantT cell epitopes. Thus
immunomodulation by sequentially infecting heterologous serotypes, which is referred to
as ' heterologous immunity , can playa role in deciding the balance between protective
immunity and immunopathology.
F. HETEROLOGOUS IMMUNITY: PROTECTIVE RESPONSES 
VS.
IMMUNOPATHOLOGY.
1. Animal models of heterologous infection:
Studies of LCMV infection in mice have shown that the CD8+ memory T cell
pool remains remarkably stable until a heterologous viral infection, which results in a
decrease in the numbers of T cells specific for previously encountered pathogens (Selin
et aI. , 1996). If, however, the sequentially infecting pathogens share cross-reactive
epitopes, then those epitope-specific cross-reactive T cells are maintained in the memory
- .
pool'and may even be enrched by the second stimulation (Brehm, et ai , 2002). When
mice immune to LCMV , PV, MCMV , or an unrelated vitussuch as vaccinia were
subjected- to heterologous challenge by these viruses; partial protection or in some cases
non-reciprocal protection ensued (Selin et aI. , 1998). For example; infection with.
LCMV, PV, and MCMV protected mice against infection with vaccinia virus whereas
vaccinia virus immune mice were not protected during challenge by the 'other viruses.
Similarly, primary infection of mice with LCMV protected them more effciently against
PV than the reverse sequence of infection. These patterns of heterologous immunity were
influenced by mechanisms such as the altered hierarchy of epitope-specific responses
and the skewing of anti-viral responses towards IFNy production or cytotoxicity. 
The immunopathological effects of heterologous immunity were seen in
experimental models ofLCMV-immune mice injected with vaccinia virus
intraperitoneally or intranasally. In the former instance, the mice developed
immunopathological lesions in their abdominal fat pads, while in the latter model the
mice displayed a distinctly altered lung pathology characterized by bronchiolar
obstruction by inflamatory cells (Selin, et aI. , 1998; Chen, et aI. , 2001).
Heterologous immunity may also be a contributing factor in autoimmunity.
Transgenic mice expressing LCMV antigens experience chronic inflammation of the
CNS when infected with LCMV but not with PV or vaccinia virus. However, rechallenge
of the mice with PV or vaccinia after the breaking of tolerance by LCMV results in
exacerbation of the disease (Evans , et aI. , 1996). These data can be extrapolated to a
situation known as 'molecular mimicry ' where viral epitopes happen to be homologous to
T -
self-antigens. Cross-reaeti:veT ce ls that get activated by viral infection may,then cause
autoimmunity by targeting all the cells that express that self-antigen.
Immunity to subsequent infections by heterologous viruses is also influenced by
the degree to which T cell functions of the memory pooLare polarized to the T I or T
phenotype. For example., in mice immunized with a recombinant vaccinia virus
expressing an RSV protein, the immune response to an RSV challenge is characterized by
an aberrant T H2 response which results in eosinophil infitration and severe lung damage
(Walzl , etaI. , 2000). , however, the mice were first primed by influenza . virus, and then
immunized with the vaccinia-RSV recombinant, the subsequent challenge with RSV
leads to an altered immune response characterized by reduced T H2 cytokine secretion and
mild eosinophila. Thus , the cytokine milieu established dming a prior infection can
influence not only the nature of the memory pool but also alter the immunopathology
caused by subsequent infections.
2. Heterologous immunity in humans:
An interesting example of how deviation of a heterologous memory response to a
secondary dengue infection might affect clinical outcome is seen in a recent study which
examined T l/T 2 transcription factor expression along with viral load and cytokine
profiles in DF and DHF patients from Taiwan (Chen, et aI. , 2005). While both DF and
DHF patients had similar viral loads, the DHF patients had lower IFNy levels, higher IL-
10 levels , and significantly lower levels ofT-bet mRA as compared to DF patients
suggesting that a strong anti-viral T I response spear-headed by IFNy can mitigate
disease whereas a predominantly T H2 response may result in increased viral load and
immunopathology. Other studies that have associated dengue immunopathology with T H
responses have reported elevated levels ofTGF/3, IL- , and IL- 18 in DHF patients
(Agarwal, et at , 1999; Mustafa, et aI. , 2001).
Similar to the previously discussed murine models of heterologous immunity
mediated by memory responses to cross-reactive epitopes, the outcome of human
infections can also be altered by pre-existing memory to unrelated viruses. Patients who
develop severe acute HCV infections have unusually strong CD8+ T cell responses to a
HCV NS3 epitope that is cross-reactive with a sequence from the influenza virus
neuraminidase protein, suggesting that a prior history of influenza infection could be a
risk factor for severe hepatic immunopathology following HCV infection (Urbani, et aI.
2005).
Given their ability to proliferate faster, quickly acquire effector fuctions and.
dominate a recall response, it is also conceivable that pre-existing cross-reactive Tcells
can provide protective immunity or enhanced resistance to heterologous viral infection.
While clear-cut examples of this scenaro and the functional mechanisms that define
protective immunity are stil under debate, some studies that show a correlation between
infection or vaccination patterns and decreased disease severity outcomes suggest such a
role for heterologous immunity. For example, individuals immunized with the live
attenuated BCG vaccine have a lower risk of developing asthma (Shirakawa, et aI.
1997). Immunization with BCG or vaccinia durng childhood (another live, attenuated
vaccine) has also shown to decrease the risk of developing melanoma later on (Krone, et
. aI. , 2005). Most recently, a statistical analysis of mortality and disease progression in
HIV patients co-infected with the GBV C flavivirus showed increased survival in those
who had ,GBV-C infection late in the timelille of their HIV -related disease as compared to
those with early co-infections (Zhang, et ai. , 2006).
These clinical observations of the immunomodulatory effects of heterologous
viral infections imply that the design of vaccines against dengue wil have to include
testing for cross-reactive T cell responses and their adverse effects. The specific
challenge that heterologous immunity poses to dengue vaccine design is discussed in the
following section.
3. hn lications for den e vaccine desi
A successful anti-dengue vaccine should be able to elicit cross-protective T cell
responses while also raising a high titer of neutralizing antibodies against all 4 serotypes.
Clinical studies which tested live attenuated tetravalent vaccines in humans reported good
seroconversion fates in both adults and children but did not resolve potential pitfalls such
as uneven immunogenicity to all four serotypes (Rothman, et aI. , 2001; Kanesa-thasan, et
aI. , 2001). Other groups have developed genetically modified infectious clones which use
!he non-structural regions from Yellow Fever 17D vaccine and the strctural genes from
DV (reviewed in Seligman and Gould, 2004). Although this ChimeriVax-Dengue vaccine
induces a strong antibody response against the E protein, the T cell responses that could
be induced by the potentially cross-reactive epitopes in the YF backbone have not yet
been studied. Other recombinant viral vectors studied include replication-defective
attenuated adenoviruses that have been shown to induce both neutralizing antibodies as
well as T and B cell responses against D2V in mice (Jaisawal, et aI. , 2003). However
more work is required to demonstrate that such viral vector or DNA plasmid
immunization approaches can induce serotype cross-protective responses. The recent
descriptions of ' original antigenic sin ' among epitope-specific T cell populations from
patients with heterologOl,JS dengue serotypes suggest that across:.protective response may
be mediated by high-avidity cross-reactive T cells since these cells are' more proficient
than low-affnity T cells at clearing the virus via cytotoxic mechanisms (Alexander-
Miller, et aI. , 1996). However, high-affinity T cells may also exacerbate disease by
secreting large quantities of pro-inflamatory cytokines. Therefore, the identification of
cross-reactive T cell epitopes on DV that stimulate appropriate T cell functional sub-sets
is an important goal for dengue vaccine design.
G. IMPACT OF NATURA VARIANT EPITOPES ON T CELL RESPONSE.
The 4 serotypes ofDV share 65% - 75% amino acid sequence homology and
this vares among the different regions of the polyprotein (Fu, et aI. , 1992). Therefore, the
T cell epitopes recognized by serotype cross-reactive T cells have incomplete sequence
homology. This thesis tested the hypothesis that these varant sequences acted as altered
peptid ligands in vitro and induced fuctional heterogeneity in the peptide-specific T
cell population.
1. T cell activation b altered tide li ands APL
APLs were originally defined as synthetic varants of a native peptide that altered
T cell responsiveness by selectively triggering some but not all T cell functions (reviewed
in Sloan-Lancaster and Allen, 1996). Ligands which stimulate a TCR to the most optimal
or fullest extent are agonists , to a lesser extent are parial agonists, and those that do not
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activate the TCR or inhibit agonist induced stimulation when presented at the same time
are referred to as antagonists. TCR signals generated by APLs are both quantitatively as
well as qualitatively different from those stimulated by the native peptide. Partial agonists
induce changes in CD3E and r chain phosphorylatio and defects in ZAP-
phosphorylati (Madrenas, et aI. , 1995). Consequently, stimulation with APLs results in
altered functional outcomes characterized by selective elicitation of proliferation
cytokine production, and cytotoxicity (Jameson, etaI. , 1993; LaFace, et aI., 1997). The
extreme sensitivity of TCR to APL binding, its impact on downstream signaling and the
eventual outcome is demonstrated by the evidence that APLs can distinguish between
fas:. and perf orin-mediated kiling, and can selectively trigger T cell apoptosis but not
cytotoxicity (Cao , et aI. , 1995; Wei , et aI. , 1999).
Biochemical and stictural studies of TCR-APL binding suggest several models
for variant ligand function that fall into three main categories - kinetic
, conformational
and stereochemical (reviewed in Madrenas and Germain, 1996). Since APL-bound MHC
have different affnities for their TCR as compared to native pMHC, the kinetic model
proposes that the activation of downstream events depends on the rate of dissociation of
the TCR and the ligand. The conformational model takes into account the sensitivity of
the TCR for the structure of the ligand and proposes that only some ligands can induce
the allosteric change that is necessary for TCR signaling independent of association or
disassociation constants. In contrast, the stereochemical model postulates that it is the
arrangement of the various sub-units ofthe TCR-oriented signaling complex and not a
conformational alteration ofthe TCR itself which dictates the strength and quality of
downstream signaling.
2. Biolo ical effects of APL signaling:
The engagement of TCR by APL and the ensuing alterations in T cell functions
can have profound biological consequences. APL signaling has consequences during
thymic development via the regulation of positive and negative selection. While,high
affnity agonists delete thymocytes , a lower concentration of the same ligands can result
in positive selection (Alam, et aI. , 1996). For mature peripheral T cells, engagement by
antagonists can cause anergy while stimulation by partial agonists can result in an
alteration in cytokine secretion patterns and a rescue from disease phenotype. This is seen
to good effect in the autoimmunity model of experimental autoimmune encephalitis
(EAE) in mice following the adoptive transfer of T H I cells specific for a self-epitope. In
contrast, the transfer ofT H2 cells specific for an APL of this same epitope suppresses
EAE via the secretion oflL- , IL- , and suppressive cytokines such as IL- I0 and TGFfJ
(Young, et aI. , 2000).
Studies of chronic viral infections such as HCV, HBV , and HIV show that T cell
Jesponses to natural viral epitope varants also influence the development of an effcient
immune response (Klenerman, et aI. , 1994; Bertoletti , et aI., 1994; Kaneko, et aI. , 1997).
Mutations which generate antagonist or partial agonist ligands lead to the evasion of
cytotoxic T cell responses in vitro which could conceivably result in viral persistence
and prolonged infection. The effects of APL on viral clearance 
in vivo were seen in a
study by Klenerman and Zinkernagel (1998), in which, the challenge of LCMV immune
mice with a variant strain bearing a single APL resulted in the generation of CTL that
21-
were predominantly specific for the original epitope and the teduced .clearance ofthe
variant virus.
Very limited information is available on the biological effects of natural viral
variants. during acute infection in humans. In a study published by our group, the in vitro
stimulation of dengue-immune PBMC generated a set of serotype cross-reactiveepitope-
specific T cells which were only parially activated by a variant epitope (Zivny, et aI.
1999). Although there was a single amino acid difference between D2 and D3 varants 
the NS3 71-79 peptide, a CTL clone isolated from a D3V immunized donor after in vitro
D3V stimulation did not proliferate or produce IFNy upon stimulation with the D2
peptide and only recognized this variant in CTL assays when peptide was added at a high
concentration. This D2 peptide was not recognized in bulk culture CTL assays or in IFNy
ELISPOT assays of uncloned PBMC suggesting that the CTL specific for this epitope are
present in very low frequencies and are oflow-affnity. This also suggests that there is a
correlation between the strength of the T cell activating signal and the responses that
follow. The pattern of cytotoxicity -= IFNy secretion 
-= 
proliferation ('-=' = requiring less
peptide) seen in this study has been reported by others (Evavold, et aI. , 1993; Hollsberg,
et aI. , 1995).
One of the aims ofthis thesis, therefore, was to further explore the breadth of this
functional heterogeneity by simultaneously analyzing for IFNy, TNFa. and MIP- l(3
responses by flow cytometr following variant peptide stimulation.
H. CHARCTERISTICS OF HUMAN CD8+ T CELL MEMORY.
1. T cell differentiation in acute infection:
Virus-specific T cells have been studied at different stages ,ofa viral infection by
assessing the expression of various phenotypic markers in relation to effector function in
order to not only understand the physiology ofthe immune response but to also determine
. why the responses against certain viruses fail to be protective. In humans, the panel of
well-researched expression markers which link surface phenotype to function includes
the two CD45R isoforms (CD45RA and CD45RO), receptors involved in lymphocyte
migration and homing (CCR7 and CD62L), co-stimulation (CD27 and CD28), and
activation (CD69 , CD38 , and HLA-DR). During acute infection, activated CD8+ T cells
upregulate the expression of CD69 within days of antigenic contact, undergo robust
expansion, and sustain high levels ofCD38 and HLA-DR late into the infection
(reviewed by Wherry and Ahed, 2004). T cell activation also induces a shift from
CD45RA expression such that most of the antigen-specific cells are now CD45RO . A
majority of the activated cells also down-regulate their expression of CCR 7 and CD62L
thereby transitioning into the peripheral circulation; CD27 and CD28 are also expressed
in the early acute stage. The effector functions of these cells are characterized by rapid
. expression of perf orin, granzyme, and secretion ofIFNy. This proliferative phase wanes
after about 2 weeks following the clearance of antigen and this is accompanied by the
apoptosis of about 95% of the antigen-specific T cells.
The memory population is established by a small pool of precursor cells which
were recently identified by their high expression of surface CD 127 (IL-7Ra) and CCR7
and loss of CD38 expression in human acute HBV infections (Boettler, et aI. , 2006).
Further heterogeneity within the memory population is defined by changes in the
expression ofCD45R isoforms , CD62L, CCR7 , CD27 and CD28. There are two main
models of memory cell differentiation based on studies of HI V, EBV , HCV, and CMV
infections in humans. In the , first model, antigen-specific CD8+ T cells differentiate from
naIve T cells into CD45RACD62L CCR7
+ '
central memory ' (T ) cells , which are
lymph-node homing cells that lack perforin and other effector functions but show a high
proliferative potential upon antigenic restimulation (Sallusto, et aI. , 1999; Champagne , et
ai., 2001). In contrast , CD45RACD62L-CCRT cells are tissue-homing ' effector
memory ' (T EM) cells. A further distinction within this subset is defined by the expression
of CD45RA and perforin (T EMRA) in cells that are terminally differentiated. In the second
model , naIve T cells differentiate into CD27 CD28+ (early), CD27 CD28- (intermediate),
and CD2TCD28- (late) memory T cells (Appay, et aI. , 2002).
2. Functional correlates of rotective immunit
Long-term persistence of immunological protection depends on both the size and
quality of the memory T cell pool. Much information on the potential of various
phenotypic sub-sets to contribute to protective immunity has been gleaned from the HIV
. infection model , paricularly from studies that compare immune responses between HIV
patients with progressive disease and HIV+ long term non-progressors (L TNP). The
earliest studies suggested that a high frequency of antigen-specific cells and a broadly
cross-reactive CD8+ T cell response targeted at multiple viral targets correlated with
better ,control of viral replication and slower disease progression (Harer, et aI. , 1996;
Ogg, et aI. , 1998). However, later studies which tracked tetramer+ T cell functions over a
period of time revealed that while the frequency of antigen specific CD8+ Tcells
remained high as measured in functional assays, there was a decline in the number of 
-,-
tetramer+ cells that secreted IFNy; TNFa, and chemokines such as CCL4and CCL5 in
patients with progressive disease' (Kostense , et ai, 2001; Scott-Algara, et aI. , 2005). The
importance of a diverse functional response has been further demonstrated in a recent
study whichsl'multaneously analyzed HIV-specific CD8 + Tcells for CDI07a expression
(a marker for degranulation) and secretion ofIFNy, TNFa, IL- , and MIP- l(J (Betts , et
aI. , 2006). The L TNPs consistently showed a broad functional profie characterized by a
high frequency of cells that could perform all 5 functions whereas the immune response
in the progressors was characterized by the low frequency or complete absence of multi-
functional subsets. There is some evidence that, in addition to the polyfunctionality of the
memory T cells , a high frequency of a specific T CM phenotype characterized by the
consistent expression of CD 127 /IL-7Ra can also contribute to protective immunity
(Paiardini, et aI. , 2005). In comparison with CD8+ T cells specific for viruses such as
vaccinia, HBV , and influenza, which are quickly cleared, and EBV , which causes a latent
infection, the expression ofCD127 is significantly reduced in CD8+ T cells in chronic
HN infection (Boettler, et aI. , 2006; Wherry, et aI. , 2006). Furthermore, the emergence
.ofCD127 expression on antigen-specific CD8+ memory cells correlated with enhanced
proliferative capacity, decreased disease markers and viral clearance in acute HBV
infection. IL- 7R mediated signaling is mainly a homeostatic mechanism to support the
survival of memory T cells and prevent them from undergoing apoptosis. This has been
convincingly demonstrated in a murine model of LCMV infection in which the kinetics
ofIL-7R expression inversely correlated with the level of apoptosis in antigen-specific
cells (Kaech, et aI. , 2003).
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Arother interesting correlation seen in acute LCMV infection in mice and acute
HBV infection inhumansis the expression ofCD127- and PD- , the receptor for
programmed death ligand - 1 (PD- L 1). PD- , a member of the CD28 co-stimulatory
receptor family, negatively regulates T cell activation, proliferation, and cytokine
production by inhibiting TCR signaling, and sensitizes T cells to apoptosis (reviewed by
Zha, et aI. , 2004). Inhibition of the PD- l signal restores functions in persistently
stimulated ' stunned' or exhausted T cells as has been demonstrated in vivo in a chronic
LCMV infection model (Barber, et aI. , 2006). Very recently, three different studies of
PD- l expression on CD8+ T cells in chronic HIV infection in humans showed that a
higher frequency ofPD- + cells were found within the HIV-specific population as
compared to populations specific for acute viruses or well-controlled persistent viruses
within the same donor, and the cells with the highest levels ofPD- l expression were the
most sensitive to apoptosis (Day, et aI. , 2006; Trautmann, et aI. , 2006; Petrovas , et aI.
2006). Additionally, PD- l expression correlated with decreased production ofTNa, and
IL-2 but not IFNy, suggesting that PD- l contributes to HIV disease progression not only
by impeding the survival of the virus-specific memory T cells but also altering their anti-
viral functions.
We and others have observed that dengue-specific T cells have an impaired
functional phenotype early during acute infection which is characterized by the inability
of these cells to produce IFNy after 
in vitro antigenic stimulation and to proliferate in
culture (Mathew, et aI. , 1999; Mongkolsapaya, et aI. , 2003). We therefore included PD-
in our phenotypic analysis oftetramer-specific T cells from dengue patient samples.
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I. THESIS OBJECTIVES
Early and enhanced immune activation are two important hallmarks of disease
severity seen in DHF patients: Serotype cross-reactive memory T cells found in dengue-
immune PBMC are likely to playa role in DHF immunopathology by getting re-activated
during heterologous dengue infection and undergoing preferential expansion as compared
to cells newly primed by the second serotype. The incomplete sequence homology
between the 4 dengue serotypes means that differences in the sequences of cross-reactive
T cell epitopes can result in altered activation profies among virus-specific memory T
cells.
Hence, our hypothesis was that (a) the stimulation of serotype cross-reactive
T cells in dengue-immune PBMC with natural epitope variants would result in a
qualitatively and qualitatively altered in vitro 
response, and (b) distinct phenotypic
and functional subsets may contribute to DHF immunopathology. This work is
presented in three parts:
Chapter Ill: a. Identification of HLA-A *02-restricted T cell epitopes
b. Frequencies of epitope-specific cross-reactive T cells in 4 donors
c. IFNy, TNFa. and MIP- l(3 co-expression and analysis of quantitative and
qualitative changes following stimulation with variant epitopes.
d. Sequential stimulation of dengue immune PBMC with variant epitopes
to directly examine functional cross-reactivity
Chapter IV: a. Comparison of epitope-specific frequencies in patient PBMC during
acute ilness and convalescence
r:;
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Chapter 
b. Phenotypic comparisons 6ftetramer+ cells between DF and DHF
patients
c. Serotype cross-reactivity in the tetramer+ T cell population
Analysis of patterns of cross-reactivity in Tcell clones following APL
stimulation:
a. Changes in cytokine production
b. Changes in sensitivity in cytolysis without alterations of other functions
c. Alterations in sensitivity to tetramet binding.
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CHAPTER II
l\IATERIALS AND METHODS
A. Experimental vaccine strains and human subjects of vaccination.
The 4 donors included in the post-vaccine immune response studies were
subcutaneously immunized with undiluted live attenuated monovalent vaccines ofthe
various serotypes as shown in Table I. Infection with dengue was confirmed by antibody
titers and virus isolation. A tlavivirus naive Massachusetts resident was also included in
the study. The Dl and D3 vaccinee developed symptoms compatible with dengue fever
(Innis, et aI. , 1988; Gagnon, et aI. , 1996). PBMC were isolated by Ficoll-Hypaque and
density gradient centrifugation. They were resuspended at 10 /ml in RPMI 1640
containing 20% FBS and 10% DMSO and cryopreserved until use. HLA typing of these
donors done at the tissue typing center at the University of Massachusetts Medical Center
(Worcester, MA) identified all the donors as HLA-A *02
Jl. Peptides
The amino acid sequence of serotype 3 H87 strain, (GenBan accession no. NC
001475) was initially chosen to generate a list ofnonamerepitopes based on the peptide
binding motif for HLA-A *0201 using the epitope prediction algorithm (available online
at (http://bimas.dcrt.nih.gov/molbio/hla bincV). Twenty-five sequences with the highest
binding scores were chosen, and the peptides were synthesized at the University of
Massachusetts Medical School Peptide Core Facility. The four identified epitopes were
identical in D3 CH53489 (GenBan accession no. AFOI7733, nonstructural; and
Table I. Vaccination history and class I HLA alleles of study subjects
Donors
Serotype and
Vaccine Strain
Months after Vaccination
PBMC Obtained
Class I HLA
Type
.'---_..-- --....--"' --_.
DI 45AZ5
D3 CH5348 168 , 192
D2 16681
D2 16681 7,44
:In
, GenBank accession-no. MS6733 structural). Variant peptides were synthesized based on
the Dl 45AZ5 (GenBank accession no. NC 001477), D2 NGC (GenBan accession no.
M29095), and D4 Sl4669 (GenBank accession no. AF326573).
C. IFNy ELIspot assay.
Multiscreen-IP filter plates (Millipore, Billerica, MA) were coated with primary
anti-IFNy mAb (lDIK) at lOJLg/ml in sterile PBS and incubated overnght at 4 C. The
plates were then washed in PBS and blocked with 10% FCS/RMI for 2 hr at 37
PBMC were thawed and washed with RPMI 1640 containing 10% heat-inactivated
human AB serum. 3 x 10 cells were added to each well at 50JLl/wei1. Peptides were
added at 10JLg/ml in a volume of 50JLl/well. Each stimulation was done in triplicate. The
plates were incubated for 16-20 hr at 37 C.Cells were then removed and the plates were
washed thrce with PBS and 0.05% Tween-PBS. 100 JLl of the secondary biotinylated
anti-IFNy mAb (7-B6- 1) at 4JLg/mi was added to the plates which were then left at room
temperature for 2 hr. Plates were then washed and incubated with 1 :400 dilution of
horseradish streptavidin peroxidase at 100JLl/well at room temperature for 45 min. Plates
were washed and incubated with 200JLl/well ofthe filtered substrate (lAEC tablet was
dissolved in 2ml ofDMF; the solution was diluted at 1:100 in NaAc solution) for 10 min
at room temperature. Plates were then washed and left to air-dry before being read
manually. The number of spots in negative control wells were averaged and subtracted
from the average number of spots in the other wells.
D. Bulk culture of-PBMC.
PBMC were thawed, and washed in 10% FCS/RMI. 3 x 
cells were
stimulated with either homologous virus (m.oj = 1) or peptide 10ILg/ i and cultured in
. 24 well plates in 10% FCS/AIM-V. The bulk cultures were tested in CTL assays between
days 7-10 after stimulation. If required, the cells were re-stimulated on day 14 with
gamma irradiated autologous PBMC in Iml of fresh medium containing 10U/ml IL-
, 0.
JLg/ml anti-CD3 mAb 12F6 , and either virus or peptide at m.
oj=1 or 10ILg/mi
respectively. Bulk cultures were re-stimulatedevery two weeks after that with allogeneic
feeders , IL-2 and anti-CD3.
E. Cloning of PBMC and maintenance of T cell lines
PBMC which had been stimulated in bulk culture for 14 days were plated at
concentrations of 1 , 3, 10 , and 30 cell/well in 96-well round bottom plates in 
501L1 of
10%FCS/AIM-V media containing 10U/ml IL-2, O. llLg/ml anti-
CD3 mAb 12F6, and 10
allogeneic irradiated feeder cells. The wells were fed with fresh media containing IL-
every 3 days for 2 weeks before being screened in CTL assays against target cells pulsed
with the peptide used in the initial stimulation of the bulk culture. The cells from the
positive wells were collected and transferred into 48 well plates and ultimately expanded
into 24 and 6 well plates with regular 2 week re-stimulations.
In some cases, peptide-stimulated bulk culture cells were first stained with
tetramers for 20min at room temperature, washed and stained with surface mAbs for CD3
and CD8 before being sorted using F ACSAria. Tetramet cells 
were collected in T cell
n n
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media and sorted into 96 ;well plates at 1 and3 cells/well and maintained as previously
described.
F. CTL assays.
Autologous BLCLs were used as the antigen-presenting target cells. They were
either infected overnight with recombinant vaccinia viruses expressing dengue virus
proteins or were pulsed with peptide at the start of the CTL assay. Cells were then
washed and labeled with 0.25mCi of Cr(Dupont NEN, Boston, MA) for 1 hr at 37
Cells were washed thrce to remove unincorporated , counted, and distributed into 96
well plates at 1500 cells/well and at an effector:target ratio of 100: 1 for bulk cultue CTL
and 10: 1 for CTL of cloned T cells. Uninfected targets were incubated with 10JLg/ l of
peptide for 30min at 37 C before the addition of effector T cells. Plates were then
incubated for 4 hr at 37 C. The plates were then harvested for supernatant using the
Skatron collection system and Cr content was measured in a gamma counter. The
percent specific Cr was calculated as follows: (cpm experimental release - cpm
. spontaneous release )/( cpm maximum release - cpm spontaneous release) x 100.
Maximum values were obtained by incubating target cells with Renex detergent and
minimum values were obtained by incubating target cells with media. All assays were
performed in triplicate and the values were averaged.
G. Intracellular staining and flow cytometry.
PBMC were thawed and washed with RPMI 1640 containing 10% heat-
inactivated human AB seru. Except in the peptide titration experiments where the
concentration varied; cells (1 0 ) were stimulated with 10 flg/ml peptide and incubated at
370C for-a total of6 h with Golgi Plug (Brefeldiri A; BD Pharingen) added during the
last 5 h. PBMC were washed with F ACS buffer (2% FBS and 0. 1 % sodium azide in PBS)
and incubated with 50 flg/ml mouse IgG for 15min at 4 C to block nonspecific binding
to IgG Fc receptors. Cells were then stained for surface markers such as CD3 (PE-Cy7
Ab; Caltag Laboratories) and CDS (PerCP Ab; BD Biosciences) at 4 C for 30 min. After
washing with F ACS buffer, cells were fixed and permeabilized with the
Cytofix/Cytoperm reagent (BD Pharmingen) for 20 min at4 C. This was followed by a
wash in Perm Wash buffer (BD Pharingen) and intracellular staining with Abs for CD69
(PE), IFN- j (FITC), TNF-l\ (allophycocyanin), MIP-' 1 (PE) at 4 C for 30 min. All Abs
were obtained from BD Pharingen. Data were acquired on a F ACSAra machine (BD
Biosciences) and analyzed using versions 4.2 , 4. , or6. 1 ofFlowJo softare (Tree Star).
In the experiments where the PBMC were co-stained with more than one cytokine
antibody, fluorescence compensation was attained by using single-color control samples.
The specificity of the co-stain was checked durng data acquisition in order to ensure that
was not due the bleeding out of one fluorochrome into an ther channel. The
lymphocyte gate included side-scatter and forward-scatter low populations that were
selected for CD3+ and CD8+ cells. The number of events collected for each sample 
vared
between 150 000 and 250 000 , depending on the donor. The number ofCD3 CDS+ cells
analyzed in each of the donors are as follows: donor 1 , 20 000:! 2 000; donor 2 000:!
000; donor 3, 000:! 3 000; donor 4 60,000:! 3 000. Each experiment included
isotype controls for each cytokine-Ab conjugate. Based on these, gates were first set on
,.:.. "
the medium.:stimulated panel , and the same gating was then applied to all other samples
within each donor.
H. CFSEstainingand sequential stimulation of PBMC
PBMC were thawed and resuspended in RPMI 1640 medium at 10 x 10 /ml. Cells were
stained with CFSE at 1 /!g/ml for 25 min at 37 C in the dark. Cells were washed three
times with cold RPMI 1640 medium containing 10% FBS, stimulated with 10 Ilg/ml
homologous peptide and 25ng/ml IL- , and incubated in the dark. IL-2 (50 U/ml) was
added on day 3. A total of 3x 10 bulk culture cells were mixed with 7 x 10 autologous
BLCLs. They were restimulated with 10 Ilg/ml of either homologous or heterologous
peptides on day 5 and day 14 , or left unstimulated for 6 hrs. Cells were then washed and
stained for surface markers (CD3 and CDS) and intracellular cytokines (IFN--
allophycocyanin, TNF--AlexaFluor 610 , MIP- PE) as previously described.
I. Study design and samples from patients in Thailand.
The study design has been reported in detail elsewhere (Mathew, et aI. , 1995).
Briefly, the subjects enrolled in the study were Thai children 6 mo- 14 of age with acute
febrile ilness and were diagnosed with DF or DHF according to WHO guidelines.
Serology and virus isolation from acute phase plasma were used to confirm acute DV
infections, and primary and secondary infections were distinguished based on serologic
response. Blood samples were obtained during acute ilness (0 -S days after study entry),
early convalescence (S- 11 days after study entry), and late convalescence (6 mo - 3 years
after study entry). PBMC were isolated by density gradient centrifugation, cryopreserved
and stored at - C. 10 HLA-B*Oit subjects were identified based on serologic HLA
class I typing on fresh blood obtained 6 mo or more .after acute ilness (22). Frozen
PBMC were shipped on dry ice to the University of Massachusetts Medical School
(Worcester, MA) for' analysis.
J. Generation ofHLA-B*07 tetraIDer
The HLA class I tetramer with HLA-B*07 restricted D2/3/4 NS3 222-231 peptide
(APTRVV AAEM) was made as previously described at the Peptide Core Facility of the
University of Massachusetts Medical School (25). Refolded monomer was mixed with
stteptavidin-phycoerythri conjugate (BD Pharmingen, San Diego, CA) at a molar ratio
of 4:1 to form tetramers.
K. HLA-peptide tetraIDer staining and phenotypic characterization of patient
PBMC
Cryopreserved patient PBMC were thawed and washed in RPMI medium containing 50%
. 3 x 101\5 cells were incubated with 0.5 /lg tetramer for 20 min at room temperature.
Cells were washed twice, left on ice for 5 min, and then stained with mAbs for cell
surface antigens using PerCp-conjugated anti-CD8 (BD Biosciences), APC-conjugated
anti-CD3 , and FITC-conjugated anti-CD69 , anti-CD38, anti-HLA-DR, anti-CCR7 , and
anti-CD62L (BD Pharmingen) for 30min on ice. Some samples were also stained with
anti-CD27 , anti-CD28 , anti-CD45RA, anti-CD45RO, and anti-PD- l depending on the
number of cells recovered after the thawing procedure. Isotope control IgG-FITC was
included for each patient at each time point. Cells were washed twice and fixed with 1 %
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Paraformaldehyde before being analyzed by F ACS. Data were acquired on a BD
FacsCalibur Flow Cytometer. 150 000 - 200 000 events were collected for each sample.
The data were analysed using FlowJo version 6. 1.1 software (Tree Star). The cells were
gated throughCD3 and CDS.
L. Tetramer and intracellular staining of T cell clones.
T cell clones were removed from cultures between 7- 10 days after re-
stimulation and washed with 10% FCS/RPMI. 3 x 10 T cells were co-cultured with 7 x
autologous BLCL and 101lg/ml peptide in Iml media for 6 hrwith GolgiStop or
GolgiPlug added for the last 5 hr. When staining for CDI07a, 20ul of PE-anti-CDI 07a
mAb was added at the beginning of the assay. Cells were washed and stained with
tetramer for 30 min at 4 C and then washed. The remainder of the protocol for staining
for intracellular cytokines is as described previously.
. CHAPTER III
. IDENTIFICATION OF HLA-A*02-RESTRICTED CDS+ T CELL EPITOPES
AND THE QUANTITATIVE AND QUALITATIVE ALTERATION OF CROSS-
REACTIVE T CELL RESPONSES BY THEIR HETEROLOGOUS VARIANTS
The selective expansion of cross-reactive CD8+ T cells present in the antigen-
specific memory repertoire during immune response to a secondary dengue viral
infection has been previously demonstrated (Mathew-etal. , 1998; Mongkolsapaya et aI.
2003; Mongkolsapaya, et aI. , 2006). While dengue-specific CD8+ T cell epitopes have
been identified in both structural and non":structural viral proteins, cross-reactivity
between serotypes is more common among the latter, since they are more highly
conserved (Kurane et aI. , 1991 and 1998; Lobigs et aI. , 1994; Zivnyet aI. , 1995). With
the exception of two recently isolated class I-restricted T cell epitopes, none of the others
are presented by HLA alleles which are predominantly found among humans living in
high-risk areas. In order to identify CD8+ T cell epitopes pres.ented by common HLA
. alleles and to study the effect of variant epitope sequences on T cell cross-reactivity, we
used an epitope prediction algorithm to generate two lists of the 25 9-mer peptides which
had the highest binding scores for the HLA-A *02 allele, based on the D2 and D3
serotypes. Twelve of these peptides appeared on both lists, albeit with different binding
scores , suggesting that these could be cross-reactive T cell epitopes (Table II). We tested
these peptides in IFNy ELlS POT assays using PBMC from donors who had received a
. single experimental mono-valent dengue vaccine corresponding to the Dl , 2 , and 3
serotypes (Table I; Chapter II).
---
Table II: Predicted HiA-A *0201-restricted 9-mer epitopescorriinon to D3 and D2
serotypes
D3 sequences
Peptide Sequence Score
2815 KLL TKP'vVDV 6755
851 IL WENDIKL 1235
1161 VLFTFVLLL 1174
2201 IVLEFFMMV 1133
2424 LLMRTSWAL 1007
2413 VMLL VLCA V 726
2965 YMWLGARYL 647
VMAFIALL 565
2148 LLLGLMILL 309
1907 ILTDGPERV 237
2353 VLLVTHYA 171
2423 LLLMRTSW A 171
. D2 sequences
Peptide SeqUetice Score
2817 RLLTKPWDV 1930
853 ILSENEVKL 148
1161 ILL VA VSFV 5534
2202. JILI;FFLIY 730
2425 LMMRTTW AL 727
2416 LL VLCLTQV 271
2967 YMWLGARL 647
AL V AFLRFL 205
2149 LLL TLLATV 1006
1908 ILTGDEERV 237
2355 FLL V AHY AI 177
2424 VLMMRTTW A 171
a The peptide numbers refer to the starting amino acid position of the epitope in the
dengue genome
b The binding score refers to the half-time dissociation ofpeptide-HLA complexes and
are arranged in the decreasing order for the D3 sequences
The sequences in bold show the 9-mers that were recognized by dengue-immune PBMCin ICS assays. 
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A. IFNyELISPOT and CTL responses to D2 and D3 peptides in Dl vaccinated
donor.
TtIe D?-. a d the D3 peptides were first tested against donors vaccinated with D2
and D3 serotype v. ccines. No IFNy pro ucing cells were detected in either ofthe D2
donors against any of the peptides and only the D3 NS4b 2423 peptide induced a
precursor frequency of 17 IFNy + spots/milliori cells in the D3 vaccinated donor. Since the
PBMC from the D2 donors and D3 donor were taken 2 years and 16 years post-
vaccination respectively, we next examined cross-reactive responses against the D2 and
D3 peptides in aD 1 yaccinee from whom PBMC were available as early as 4 months
post-vaccination. The IFNy responses against the D3 peptides were in general higher than
those against the D2 peptides (Figure 2A, 2B). This may be due to the greater homology
in sequence between D 1 and D3 serotypes. There were no responses detected against any
of the D2 peptides in PBMC obtained at 1 year, suggesting a loss of cross-reactive cells
over time. The specificity of the response also changed over time with different peptides
dominating the response at 4 months as compared to the other time points. Of the 4 D2
. peptides and 10 D3 peptides that induced more than 40 IFNy + spots/milion cells in the 4
month bleed, CTL responses against only the D2 493 peptide (34%) and the D3 2353
peptide (26%) were detectable in 7 day old bulk cultures stimulated with the homologous
Dl virus (Figure 3). The recognition of these two sequences at the bulk culture level
might be attributable to the fact that the amino acid sequences between the D 
(homologous) serotype and the heterologous D2 or D3 varants differ by one (493) or two
(2353) residues.
';,
100
Figure 3: Specific lysis of peptide-pulsed autologous targets. Dl immune PBMC were
stimulated with Dl Vat m.oj of 1. After 7 days , the bulk culture (effectors) was tested for
virus-specfic CTL activity against autologous BLCL (targets) which were uninfected, or
infected overnight with recombinant vaccinia expressing Dl NS3 , or which were pulsed
with 25/-g/ml peptide for 30 min before the assay. % specific lysis was calculated as
described in Chapter II, Materials and methods.
2148 2353D1 NS3 vac
vac
493 2202 2423none
8E:T = 90:1 DE:T = 30:1 
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B; Responses to predicted epitopes,byintl'acellular staining for IFNy and TNFa:
Since the responses detected using IFNy ELISPOT were low in magnitude, we
continued our analyses using a flow cytometry-based approach to simultaneously detect
the secretion of other cytokinesand the expression of the activation marker CD69. We
first studied PBMC from the D3-immune HLA-A *02+ donor. Cells were stimulated with
10ug/ml of peptide. Frequencies of more than 0. 1 % of CD69+ IFNI' producing cells were
detected in the CD3+ CD8+ T cell population in response to stimulation by 4 of the 25
peptides (Figure4A). The highest response was to the NS4b 2353 peptide (0.45% CD69
IFNl cells), which had also stimulated high responses in the Dl donor. The frequency of
cells specific for NS4b 2353 , NS4b 2423 , and NS4a 2148 were higher than the frequency
of cells specific for two previously identified HLA-B*62 epitopes in this donor (Zivny et
aI. , 1999). Three of the 4 peptides stimulated responses of more than 0. 1 % even at 0.
ug/ml (Figure 4C). Responses to these four peptides were also detected in the 3 other
donors who were vaccinated with other dengue serotypes (Table III). No responses were
detected in a HLA-A *02 negative dengue-immune donor or in a HLA-A *02 positive
flavi-na'ive donor (data not shown). In the D3-immune donor, all 4 peptides induced a
TNFa response which was higher than the corresponding IFNy response, suggesting that
the epitope-specific population was comprised of sub-populations of cells which secreted
TNFabut not IFNy. In addition to IFI', TNFa and CD69 up-regulation, 3 of the 4
peptides also induced proliferation responses as measured by CFSE dilution (Figure 4B).
Cells that underwent more than 6 divisions over 5 days ranged from 5% to 16% of CD3
CD8+ T cells remaining in the culture with the highest proliferation being in response to
the D3 2423 peptide.
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. C. Analysis of IFNy, TN Fa, andMIP-l(j co:-expressioD following heterologous
stimulation by variant sequences of the NS4b 2353 epitope
Because of variation in amino acid sequences between the four dengue serotypes (Table
IV) and because the evidence from initial studies that showed that vaccinated individuals
responded to heterologous serotypes, we next investigated the range of cytokine
production within each epitope-specific T cell population and determined whether these
expression profies were skewed following stimulation with variant sequences of these
epitopes from heterologous serotypes. Of the four epitopes, the E493 and the NS4b 2423
epitopes are highly conserved among all four serotypes whereas the NS4a 2148 and
NS4b 2353 epitopes are less conserved (Table IV).
We were interested in examining TNFa and MIP- responses to the epitopes
since high levels of both these inflamatory factors are produced during dengue infection
(Cardier, et aI. , 2005; Spain-Santana, et aI. , 2001). We hypothesized that variant peptides
might skew the response to a TNFa/MIP- profile. Responses to NS4b 2353 , which was
the most immunogenic epitope in all four donors, are shown in figure 4. PBMC were
stimulated with each of the peptide variants and double stained for IFN)'/TNFa (Figure
5A), and IFNy/MIP- l(j (Figure 5B). In 3 ofthe 4 donors, the highest total cytokine
responses were stimulated by the heterologous varants of this epitope. The highest
response to the homologous peptide was seen only in the donor who had been immunized
16 years prior to obtaining the PBMC, suggesting that the pattern in this donor could be
due to the attrition of cross-reactive T cells over time. The cytokine response in each
donor was composed oflFNl, TNFa IFNy TNFa , and IFNy MIP- + cells.
Start Protein Serotype Sequence
position ues
2353 NS4b (1II 119)
. D2
2423 NS4b (181- 189)
2148 NS4a (56-64)
-3 n
. . 
Tab1e IV: Sequences of epitope&!and their heterologous variants
493 E (211-219)
Numbers indicate the position of the epitope within each viral protein based on the
dengue 3 serotype
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The relative sizes of these subsets, varied depending on both the donor as well as the
serotype of the stimulating peptide. In 3 of the 4 donors, the frequencies ofMIP- l(t eells
were higher than the corresponding frequencies of IFNy + and TNFot cells. In the same 3
donors , the D2 and D3 varants induced the highest frequencies ofIFN'YITNFa and
IFN'Y/MIP- I(J cells. Other changes were seen in the hierarchy of the various subsets , with
different variants skewing the response towards different cytokine producing cells. For
example, in donor 1 , the D3 variant induced 0.76% IFN'Y IMIP- 1(J+ and 0.57% MIP- l(J
cells whereas the D2 and D4 variants stimulated cells to produce MIP- l(J+ alone. The
skewing of the cytokine profile was also apparent in donor 4 where the prevalent
populations in response to D2 peptide stimulation were TNFa , IFN'Y TNFa and
IFNy IMIP- I(J+ cells. In contrast, the prevalent populations in response to D3 peptide
stimulation were IFNl andIFNy TNFa+ cells.
D. Analysis of quantitative and qualitative changes in response to the variant
sequences of all 4 epitopes by triple cytokine staining
Since the initial double staining experiments revealed the existence of distinct
subsets of epitope-specific cells that were either single positive for each cytokine or
double positive for IFN'YITNFa and IFN'YIMIP- l(J, we wanted to further define the
heterogeneity of these populations by analyzing for the co-expression of all 3 cytokines.
An example of the gating analysis of SEB-stimulated samples stained simultaneously for
IFNy, TNFa, and MIP- l P is shown in Figure 6. Seven different populations of cytokine
+ Q Q+ 
pro ucmg ce s IFNy, TNFa , MIP- 1,. , IFNy TNFa , IFNy IP- l,., TNFa MIP- l(J ,
IFNy TNFa MIP- l(J+ were identified (Figure 6D-6I).
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Results of such analyses were highly reproducible. In the D3-immune subject
(donor 2) from whom large numbers ofPBMC were available, the analysis was repeated
in 3 separate experiments; in almost all cases, the standard deviation was less than or
equal to 0.03% (Table V) and the pattern of responses across serotypes was consistent in
all repeated experiments.
The total frequency of CD8+ T cells responding functionally to all 4 epitopes
ranged from 0.65% - 4%, with cells responding to the variants of the NS4b 2353 epitope
dominating the overall response in all 4 donors (Figure 7 A). When the response to each
epitope varant was compared across donors, the same epitope variants usually induced
the highest quantitative response in all donors regardless of the serotype that they were
immunized with, as seen with D3 NS4b 2343 and D2 NS4a 2148 (Figure 7B , 7C). Higher
responses to heterologous variants were more common than the responses to homologous
peptides.
Heterologous stimulation also altered the qualitative nature of the response, since
all the epitopes and their variants either did not stimulate all 7 cytokine subsets or altered
the relative sizes of these subsets. These changes were both donor-dependent as well as
epitope variant-specific. Thus, although the D3 NS4b 2423 and D2 NS4a 2148 variants
induced the highest responses in all 4 donors , the profile of the response to each variant
differed in each donor. Thus the heterologous response to D3 NS4b 2423 in donors 1 , 3
and 4 were dominated by MIP- l(3 or TNFawhile the homologous response to this
peptide in donor 2 was dominated by MIP- l(3 and IFNy. While the heterologous response
to D2 NS4a 2148 in donors 1 and 2 were dominated by IFNy producing cells , the
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homologous response in donors $ and 4 was represented equally by IFNy/TNFa and
IFNyIMIP- 1 (3 populations , respectively.
In other examples of donor-specific changes, stimulation ofD 1 immune PBMC
(donor 1) with D3 NS4b 2353 resulted in all 7 functional populations with the IFNtMIP-
1(3+ subset being the largest. In contrast, the Dl NS4b 2353 peptide induced IFNt,
TNFa , MIP- , and a very small population ofTNFa MIP- + cells (Figure7A).
Similarly, in donor 2 (D3 immune), although the homologous D3 NS4b 2353 and NS4b
2423 peptides induced 6 different sub-sets of cytokine-producing cells , stimulation with
the other variants of these epitopes only gave rise to mainly IFN-l and MIP- l(3+ cells
(Figure 7 A, 7B). In contrast, in donor 3 , although the responses to all variants of all the
epitopes were mediated by all 7 subsets, the frequency of cells producing MIP- was
lower than the frequencies of cells producing IFNy andTNFa.
This extensive functional heterogeneity of the population of cells re-activated 
vitro during a secondary stimulation suggests that the quality of the recall response
during heterologous dengue infection 
in vivo will depend on which ofthese subsets
llndergo selective expansion and dominate the secondary response.
E. Sequential stimulation of dengue immune PBMC by different variant peptide
sequences directly reveals cross-reactive T cells
In the experiments described above, PBMC immune to one serotype responded by
producing cytokines when stimulated with peptides from other serotypes, showing that
these epitopes could stimulate cross-reactive responses. However, the results of these
experiments did not indicate if the same population of epitope-specific cells was
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responding to the variant peptides or ifeach variant peptide activated a different
population of epitope-speci fie T cells. In order to understand this , we developed an assay
which would measure functional responses ofthesame cell population to two different
peptide stimuli.
PBMC were stained with CFSE at the time of stimulation with the homologous
peptide (first stimulus). After 5 or 14 days , theeells were washed and re-stimulated for 6
hrs with the same or heterologous peptides and stained for cytokine production (second
stimulus). The cross-reactive population would be represented by the CFSE1owcytokine +
group, the population specific for the homologous peptide would be represented by the
CFSE10Wcytokine- sub-set and the population specific only for the second heterologous
peptide would be represented by the CFSEhighcytokine + sub-set.
Stimulation of Dengue 3 immune PBMC with the homologous D3 NS4b 2423
peptide induced proliferation of epitope-specific CD8+ T cells. By day 5 , fully divided
CD3 CD8+ cells constituted 16% of the culture and increased to 48% by day 14
(Figure 8A). Re-stimulation with homologous peptide on day 14 induced IFN'l
production by 67% of the divided cells; 0.25% - 0.52% ofthe undivided cells that
remained undivided at day 5 of culture also produced IFNy after restimulation. However
by day 14 of culture, essentially none of remaining undivided or partially divided cells
were capable of producing IFNy + after re-stimulation.
In contrast, only 22% ofthe day 14 proliferated cells were IFN't following D2
peptide stimulation. The number of cells which secreted IFNy in response to D 1 and D4
peptide stimulation was even lower. This suggests that a third of the expanded D3 NS4b
2423-specific T cell population was cross-reactive for D2 NS4b 2423 but had very little
cross-reactivity for the Dl and D4 variants. Since direct ex-vivo stimulation of this
. donor s PBMC with Dl , D2 , andD4 peptides induced comparable levels of cytokine
production (Figure 7B), these results suggest that under long-term culture conditions
clones that are cross-reactive for D2 arid D3 sequences alone have a proliferative
advantage. This pattern of cross-reactivity was consistent with that seen in NS4b 2423-
specific T cell clones obtained from limiting dilution. Most of the clones derived from D3
peptide stimulated bulk lines as well as the bulk culture itself were highly cross-reactive
for D2 peptide and less so for D 1 and D4 variants in cytolysis assays (Figure SC).
. The pattern of cytokine staining byCFSE!OW cells in response to re-stimulation
with homologous D3 or heterologous peptides also differed. The intensity of IFNy
staining of CFSElow cells was lower after stimulation with heterologous D2 peptide than
after stimulation with homologous D3 peptide. All of the CFSElowIF'l cells in cultures
stimulated by homologous peptides co,.expressed TNFa and MIP- li3 (Figure SB). In
contrast, there was a substantial population of cells (16% - 32% ofCFSEIOWIFNy+
population) which did not express MIP- l p in response to heterologous stimulation. The
. majority of the CFSE IOWIFNy- population did not express TNFa. But 10% - 15% of these
cells expressed MIP- l(3 following re-stimulation with D2 and D3 peptides revealing an
unexpected pattern of functional heterogeneity represented by this population of
CFSE IOWIFNfTNFa MIP- l p+ cells.
In order to determine if these patterns of cross-reactivity was epitope-specific , we
examined responses to variants of other epitopes. The response to a HLA-All *01
restricted epitope (Dl NS3 130) and its variants was studied in Dl immune PBMC by
staining with tetramer and anti-IFNy. The D2 and D3 variants of this epitope differ by
one and two amino acids , respecti,vely, from the Dl sequence (Figure 9A), and T cells in
Dl peptide-stimulated bulk cultures are cross-reactive for both variants since they
effciently lyse both D2 and D3-pulsed autologous targets (Figure 9C). The cross-
reactivity works in the other direction with D3 peptide stimulated bulk cultures
recognizing Dl and D2-pulsed targets equally well in CTL assays. However, the D2
peptide-stimulated bulk cultures showed low frequencies of epitope-specific CTLs and
poor cross-reactive recognition ofDl and D3 pulsed targets.
Dl immune PBMC were stimulated on Day 0 with the homologousDI peptide
re-stimulated on Day 8 with the three variants for 6 hr, and stained with the
corresponding tetramers or for intracellular IFNy. Dl-tetramer staining and IFy
intracellular staining both showed epitope-specificity in only 6% of the total cells for
homologous peptide re-stimulation while staining with the variant tetramers detected 3%
of cells that were cross-reactive for D2 and 2% of cells that were cross-reactive for D3
(Figure 9B). This hierarchy of cross-reactivity was similar to that observed by staining
for IFNy and unlike that observed by CTL lysis in the DI bulk cultures (Figure 9C)
s.uggesting that cross-reactivity is segregated by effector function
However, tetramer staining may not accurately measure the size ofthe antigen-
specific population. Activated T cells may have decreased avidity for tetramer due to
changes in the reorganization ofthe TCR on the cell surface (Drake et aI. , 2005; Blohm et
aI. , 2002). We observed such a result when we examined the sequential stimulation
response ofD3-immune PBMC to a HLA-B*07 restricted epitope NS3 222-231 and its
D 1 variant. The difference of a single aa (D 1 :Ser Glu) (Figure 10A) between the two
sequences had little effect on the ability of bulk cultures stimulated with the D2/3/4
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peptide to cross-reactively recognize and lyse D1-pulsed target cells (Figure lOB).
However, the reverse pattern of cross,.reactivity was not seen since the Dl-peptide
stimulated bulk cultures were able to minimally recognize the D2/3/4 variant at very high
concentrations.
This pattern in the cross-reactivity of response between cells specific for the two
sequences was seen in the IFNy response of the CFSE-stained cells and in their ability to
bind tetramer. The bulk culture stimulated with the heterologous DIpeptide on day 0 did
not produce IFNy upon stimulation with either peptide on day 13 nor show affinity for the
tetramer, suggesting that the D3-specific memory cells in this donor s PBMC had low
avidity for the variant peptide and did not proliferate (data not shown).
In contrast, in the bulk culture stimulated on day 0 with the homologous D2/3/4
peptide, 10% of the total culture produced IFNy upon re-activation with the same peptide
and a third of these cells ( 3%) were cross-reactive for the variant peptide (Figure lOC
bottom panel). Homologous re-stimulation also induced IFNy production among 6% of
the incompletely proliferated CFSEmid-
high population
, which was a pattern not observed
with the other peptides studied (Figures 8 , 9). The pattern oftetramer staining, however
was surprisingly different from that of cytokine production. Only 3% of cells stimulated
with the D2/3/4 peptide on day 0 were tetramer+ on day 13 and were all found among the
CFSE10w population. In the cultures that were re-stimulated on day 13 , only 1.7% ofthe
CFSE10W cells were tetramet suggesting that the remaining 1.3% had down-regulated
their TCR upon re-activation. These tetramer + cells were also mostly IFNl but there was
a significant fraction oftetramer+ cells which did not secrete IFNy (Figure l1A).
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We also examined the pattern of tetramer staining among the CFSEmid-
highIFNl
populatio and found that the tetramer subset was included within this populati
(Figure liB). We interpret these results to mean that there is' a hierarchy in the functional
avidity of these antigenMspecific cells 
with the cells of the highest avidity retaining the
ability to bind tetramer and produce IFNy after having fully proliferated, the proliferated
cytokine-producing but non-tetramer-binding cells being of intermediate avidity, and
those that produced cytokine without fully proliferating or binding tetramer to be of low
avidity. In this sense, the 3% of the D2/3/4-specific bulk culture cells (Figure 10B) which
produced IFNy in response to the heterologous peptide would have the same high avidity
to the variant as to the homologous peptide.
F. Chapter Summary
Our objective was to study the patterns of cross-reactive responses to
immunodominant T cell epitopes and their variants in dengue-
immune PBMC in order to
understand the complexities ofthe secondary immune response to heterologous dengue
serotypes. We identified 4 novel HLA-A*02 restricted epitopes which were recognized in
the 4 available vaccinated donors. The frequencies of the cells specific for these epitopes
as measured by intracellular IFNy production were higher than those measured during
convalescence in infected subjects (Loke et aI., 2001; Mongkolsapaya et aI.
, 2003 and
2005). Stimulation of dengue-immune PBMC with the variant sequences ofthese
epitopes altered both the size and the functional profile 
ofthe secondary response as
compared to homologous peptide stimulation. The quantitative changes seen in response
to the altered peptides were:
In each donor, the peptide that induced the highest response was
frequently a heterologous sequence
The same variant of some epitopes (D2 2148 and D3 2423) induced the
highest response in all donors regardless of their primary serotype
Of the 4 epitopes , each donor showed the highest response to one of the
variants ofNS4b 2353.
Stimulation with variant sequences also induced qualitative changes in response:
The numbers and relative frequencies of the various cytokine-producing
subsets varied by donor
Within a donor, variant peptide stimulation altered both the types of subsets
that responded, as well as their frequencies.
We also developed a novel assay which allowed the direct demonstration of
serotype cross-reactive responses to variant peptide stimulation. The sequential
stimulation of CFSE-stained PBMC with homologous peptide followed by heterologous
peptide (after a proliferation interval) revealed cross-reactivity patterns and hierarchies of
functional avidity. Responses to the secondary (heterologous) stimulation were mediated
by cells that had divided after primary stimulation with the homologous sequence, i.
cross-reactive cells.
Thus, the presence of a diverse functional epitope-specific population and the
changes in the frequencies of functional subsets following heterologous secondary
stimulation suggest that the nature of the memory response (protective vs pathologic)
could be determined by the dominant functional subset. These changes in functional
profiles were both donor-dependent (i. , primary serotype) and epitope-specific.
Additionally, the higher immunogenicityan.d avidity of the variants ofD2 andD3
serotypes suggest a role for the serotype ofthe secondary infection in determining disease
severity.
CHAPTER IV
ANALYSIS OF FREQUENCY, KINETICS OF RESPONSE AND PHENOTYPE
OF EPITOPE-SPECIFIC CD8+ T CELLS DURING ACUTE DENGUE DISEASE
AND CONVALESCENCE IN THAI PATIENTS
Studies which examined T cell responses during acute dengue illness have
reported a correlation between disease severity and increased T cell activation. In these
studies, patients with DHF had elevated levels of cytokines and soluble cytokine
receptors early in the illness, and increased expression of CD69 on CD8+ T cells (Green
et aI. , 1999). Quantitation o(epitope-specific T cells via IFNy ELISPOT and tetramer
staining showed increased epitope-specific T cell frequenties in DHF patients as
compared to those with mild dengue disease (Zivna et. , 2002; Mongkolsapaya et aI.
2003; Mongkolsapaya et aI. , 2006). However, little has been published on the phenotype
of responding T cell sub-sets during dengue infection. In studies performed by
Mongkolsapaya et ai, the frequencies oftetramer+ cells were found to be low durng early
illness with peak frequencies occurrng at 2 weeks after the resolution of fever. Since the
characteristic symptoms ofDHF, namely plasma leakage and shock, appear at the time of
defervescence, this finding is at odds with the notion that activated CD8+ T cells
contribute to DHF immunopathology. In order to learn more about the nature of dengue-
specific T cells in terms of their changing frequencies and phenotypes through the course
of secondary immune response, we studied CD8+ T cells specific for a HLA-B*07
restricted NS3 epitope in PBMC obtained during acute illness and convalescence from 10
dengue-infected Thai subjects.
A. Identifcation of HLA-B*07 testricted NS3-222-231 epitope and construction of
tetramer:
The HLA-B*07-restricted CD8+ T cell epitope NS3.221-232 was initially
identified as a 12mer epitope LAPTRVV AAEME recognized by convalescen.t-stage
PBMC of a D4 virus-infected patient and T cell clones established by limiting dilution
(Mathew et aI. , 1998; Zivna et aI. , 2001). This sequence is conserved among D2V , D3V
and D4V and differs by 2 amino acids - serine for alanine at position 9 and alanine for
glutamic acid at position 12 in the D 1 V sequence. This epitope was recognized in IFNy
ELISPOT assays in several dengue-infected HLA-B*07 donors duriIlg acute infection
and convalescence. T cell clones specific for the 12merepitope were able to recognize
the 10mer NS3 222-231 epitope in CTL assays but not the 2 predicted 9mers , 221-229
and 222-230, present within this region. Tetramers folded with the 9mer 221-229 did not
stain these cells (data not shown). We therefore constructed a HLA-B*07 tetramer with
the peptide corresponding to the 10mer 222-231 for further studies. This tetramer
efficiently stained an HLA-B*07-restricted patient PBMC-derived cell line (Figure 12A).
, The specificity of the tetramer was confirmed by staining an HLA-B*07-restricted cell
line specific for a different NS3 epitope (Figure 12B) as well as PBMC taken from a
dengue-immune HLA-B*OT donor (Figure 12C) and from a dengue-naIve HLA-B*07
donor (Figure 12D). The tetramer was also recognized by around 4% ofCD8+ T cells
from a dengue-immune HLA-B*07+ patient (Figure 12E).
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B. Frequencies of epitope-specific cells in patient PBMC during acute ilness and
convalescence:
The 10 patients enrolled in the study were all under 15 years of age. There were 5
DF and 5 DHF cases , and all but 1 subject were serologically defined as having
secondary infections with dengue virus (Table VI). Samples were obtained as early as 5
days before the resolution of fever and as late as 9 days after defervescence.
Convalescence samples were obtained during follow-up visits at 6 months - 1 year after
the resolution of ilness.
NS3 222-23 I-specific T cells were detected in all donors , with frequencies
ranging between 0.23% - 8. 12% ofCD8+ CD3+ T cells in acute stage samples stained
with the tetramer corresponding to the D2/3/4 sequence (Figure 13A, 13B). These
frequencies are higher than those detected by IFNy ELISPOT assay in some of these
patients in a previous study (Zivna et aI. , 2001) and also higher than those detected
during acute ilness by other groups. Also , tetramer + cells were observed even in those
PBMC in which no IFNy responses had been detected.
Serial bleeds were available in 5 donors during acute ilness, starting as early as 5
days before defervescence. In 2 ofthese donors, the kinetics ofthe response was seen to
change rapidly. In subject C95-098 with secondary grade II DHF, the frequency peaked
at 7.4% ofCD8+ T cells 3 days before defervescence and underwent a 3- fold decrease by
day 5 after fever resolution. In subject C94-094 with secondary grade I DHF, tetramer+ T
cells underwent a massive 6-fold expansion from 1.5% to 7% ofCD8+ T cells within a
day and underwent a 3-fold decrease a day later (Figure 13C). In the remaining three
donors, 2 of whom had DF , the frequencies oftetramer+ cells were lower than in theDHF
Table VI:' Characteristics ofpatiynts in the study.
HLA Class I Alleles
Subiece Diagnosis Serology SerotyPe
C95-029 Primary
C96-089 Secondary
C94- 115 Secondary
K97 -093 Secondary
C99-0 14 Secondary
C94-094 DHF grade Secondary
C94- 132 DHF grade 2 Secondary
C95-098 DHF grade 2 Secondary
C97 -036 DHF grade 2 Secondary , 75
C97-014 DHF grade 3 Secondary , 13
Age of subjects: 6 mo - 14 yrs
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donors on all the study days. Th peak of the response again occurred on the day of
defervescence with tetramer + cell numbers decreasing thereafter.
The magnitude of response was also seen to correlate with disease severity.
Tetramet T cell frequencies were higher in DHFpatients both during acute 
ilness as
well as in convalescence. While the frequencies oftetramer
+ cells were in general lower
during convalescence than those observed during acute ilness
, 2 of the DHF patients had
frequencies as high as 1.8% and 3% tetramet T cells even at 
6 months following
recovery (Figure 13C).
C. Phenotypic analysis of tetramer CD8+ T cells:
The changes in phenotype which occured during the activation and expansion of
antigen-specific cells during dengue infection were studied by staining patient PBMC
with antibodies for activation markers CD69 , CD38 , and HLA-
, homing receptors
CCR 7 and CD62L, and when cells were available
, for markers such as CD45RA and
CD45RO that would help in the differentiation of memory subsets as well.
An example of the staining for activation markers is shown in Figure 14.
The expression of CD69 in both DF and DHF patients decreased following the clearance
of virus by day 9 after being admitted into the study (Figure 15). While fewer than 15%
of the tetramer+ cells were CD69+ in DF patients
, this number was as high as 80% in the
3 of the 4 DHF patients. There were no CD69+ cells found during late convalescence (6
months post-infecti ) in DF donors whereas 
10% oftetramer+ cells in the DHF patients
expressed CD69 at this stage. All donors also showed a
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Figure 15. Kinetics of expression of activation and differentiation markers on tetramer+ T
cells: Patient PBMC obtained from both acute phase of ilness (Days 1-8) and convalescence
were co-stained with tetramer and CD69 , CD38 , CCR7, and HLA-DR. Populations gated for
CD3+ CD8+ staining were fuher analyzed for stainng by tetramer and surface mAbs. The
percentages shown in the graphs indicate the percentage of marker+ cells withi the tetramer+
population.
CCR7
the presence of other activated T ells.
In contrast to the CD69 pattern of expression, - 80% or more of the tetramer
cells were CD3S+ by day 5 in all the donors in acute ilness , and remained-high in some
donors even during convalescence (Figure 15A G). There was donor-to'-donor
variability in the expression ofHLA-DR on tetramer+ cells. In general, HLA-
expression was higher in the acute stage than during convalescence. However, one patient
showed sustained high expression ofHLA-DR into convalescence (Figure 15C), and one
patient showed higher HLA-DR expression during convalescence as compared to the
acute stage (Figure 15G).
The tetramer+ cells in all 4 DF donors and 2. of the DHF donors studied were
predominantly CCRT with - 20% oftetramer+ cells expressing CCR7 in the post-
defervescence stage. This suggests that most of the epitope-specific T cells in the
periphery are effector T cells at the time of viral clearance. CCR7 expression was
restored in DF subjects at the convalescent visit, with up to SO% oftetramer+ cells being
CCR7 . In contrast, in one DHF subject from whom multiple bleeds were available
, during the febrile stage, almost none of the tetramer+ cells expressed CCR7 durng acute
disease and were still CCR in convalescence. This low expression of CCR 7 during
convalescence was also seen in the other DHF subjects suggesting that the majority of the
epitope-specific T cells that are present in the post-DHF repertoire have retained an
effector memory phenotype.
Several recently published studies of CDS+ T cell responses durng chronic
infection have shown the expression of programmed death receptor - 1 (PD- l) on antigen-
specific memory T cells to correlate with impaired cellular functions and increased
specific memory T cells to c01Te1 te with impaired cellular functions and increased
sensitivity to apoptosis (Day, et a. , 2006; Petrovas , et aI. , 2006; Trautmann, et aI. , 2006).
Since we and others have observed that dengue-specific CDS+ T cells show decreased
ability to proliferate and secrete IFNy in the early stages of acute infection, we examined
the dengue tetramer+ cells for PD- lexpression. In both the DF.and DHF donors tested
PD- l was expressed on more than 90% of the tetramer+ population at the peak of the
acute response while being completely absent in the convalescent samples (Figure 16A,
16B). Interestingly, PD- l was also upregulated on a significantly large portion of the
tetrame( CD8+ T cell population, which may explain the profound immunosuppression
of T cell responses seen immediately following viral infection.
D. Serotype cross-reactivity of tetra mer + cells:
We were next interested in further analyzing the epitope-specific response for
serotype cross-reactivity since the patients included in the study had secondary dengue
infections with known viral serotypes. PBMC taken around the time of defervescence
, from 2 DHF patients with secondary D3 infections were stained simultaneously with
tetramers containing the Dl varant as well as the D2/3/4 sequence. In one patient, the
tetramer + response on fever day - 1 was represented by a population of cells which were
either cross-reactive (0.94%), or specific for the Dl sequence ( 2%) with fewer cells
being specific for the secondary serotype (0.41 %) alone (Figure 17 A). However, 2 days
later, the epitope-specific response had altered such that fewer cross-reactive cells were
seen and most of the tetramer+ cells were specific for the Dl variant sequence alone. The
opposite trend was seen in another patient with regard to the changing avidities of the
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epitope-specifi response over time. The total tetramer+ CD8+ frequencies in this patient
was less than 0.3% on fever day - 1 with.few' cells staining with both tetramers and most
ofthe cells with higher avidity for the variant D1 tetramer (Figure 17B). On fever day + 1
the total tetramer+ popula.tion had expanded 6-fold to 1.88% and a majority ofthese cells
now showed higher avidity for the tetramer containing the homologous D2/3/4 sequence.
These data suggest that the response to a secondary serotype can vary in overall avidity
over the time course of the response with T cells with higher avidities for the infecting
serotype disappearng over time or vice-versa.
E. Chapter summary:
Our objective was to study the kinetics of the antigen-specific T cell response in
dengue-infected subjects in order to determine if the frequency and phenotypic profie of
tetramer+ T cells in DHF patients is different from that found in patients with DF and
thereby understand the basis for DHF immunopathology in humans. We studied the NS3
222-231 specific responses in 10 patients (5 DF; 5 DHF) and found that:
The magnitude of the response correlated with disease severity both during acute
illness as well as during convalescence.
Tetramer+ cells were found as early as 5 days before defervescence and the peak
of the response occurred around the day of defervescence.
Tetramer+ cells detected early during acute ilness had a phenotype consistent
with recent activation as seen by CD69 staining, with DHF patients showing
higher percentages oftetramer CD69+ cells than DF patients.
---
Tetramer+ cells from DHF patients showed low CCR7 expression even during
convalescence indicating an altered funcational capacity.
A majority of the tetramer+ expressed PD- l during acute ilness. PD- as also
expressed on about 50% oftetramer- CD8+ T cells during this time.
Simultaneous staining ofPBMC from 2 DHF patients with homologous and
heterologous tetramers showed serotype cross-reactive responses in both with the
avidities of T cell for both tetramers changing over the time course of infection.
Our results show that the T cell response to secondary dengue infection is mediated
by a heterogeneous population of memory CD8 T cells that undergo a robust program of
expansion during acute infection. These virus-specific T cells persist in high numbers
even after the viremic phase has ended. This study strengthens the view that DHF
immunopathology is a consequence of an early and enhanced immune response
;:11 .
CHAPTER V
NATURAL EPITOPE V ARlANTS MAY MODULATE IMMUNE RESPONSE TO
SECONDARY DENGUE INFECTION BY INDUCING FUNCTIONAL
DICHOTOMY IN MEMORY CDS+ T CELL CLONES
Our studies on post-vaccination responses in individuals immunized with a single
dengue serotype showed a functional heterogeneity which appeared to have a unique
signature in each individual (Chapter III; Bashyam, et aI. , 2006). Antigen-specific CD8
T cells responded to natural variant peptides from heterologous serotypes in a maner
which was both subject-specific as well as peptide/variant-specific. For example, one
patient showed strong TNFa responses to stimulation by all peptide variants while the
single variant of some peptides induced the strongest overall response in all vaccinees
regardless of their primary serotype.
Other aspects of functional heterogeneity were revealed in peptide/variant
stimulated short-term bulk cultures. The sequences which induced the highest cytokine
responses in direct ex vivo assays did not always induce the strongest proliferative
. response in a CFSE-based assay which tracked both the expansion and cytokine
production of antigen-specific cells in response to sequential stimulation by homologous
and heterologous peptides. While the parameters of this study precluded us from making
connections between a functional profie and the corresponding clinical outcome, our
results suggested that the variation in the responses could reflect the emergence of a
specific set of antigen-specific clones with different functional avidities for cognate vs.
altered ligands during secondary infection.
Our third aim , therefore , was to examine the patterns of heterogeneity that exist at
the clonal level in response to varying ligand concentrations and the difference in
functional profiles between different clones which have the same specificity.
A. Isolation of serotype cross-reactive CD8+ T cell lines and their specificities.
All the CD8+ T cell clones described in this section recognize different epitopes
on the NS3 protein (Table VII). TheHLA-B*62 restricted clones were previously
isolated from the PBMC of the D3 immune donor after stimulation with the D2 peptides
from PBMC obtained 13 years post-vaccination (Zivny , et aI. , 1999). The HLA-B*07-
restricted clone 11 E was isolated from the convalescent PBMC of aD 1 infected donor
after stimulation with a Dl peptide (Zivna, et ai, 2002). These clones were expanded in
media containing IL- , anti-CD3 mAb , and allogeneic irradiated feeder cells and allowed
to rest for 10 days after re-stimulation before being used in experiments.
The HLA-A*1101 epitope was originally described by Mongkolsapaya, et aI.
(2003) in Thai donors. We found that this epitope and its variants were recognized by our
D 1 vaccinee as well, with the D3 peptide stimulating the strongest IFNy response but the
Dl tetramer showing the highest staining (Figure 18A). Tetramer staining and cytokine
secretion seemed to be functionally segregated since there were no IFNltetramer
observed, and the hierarchy of the frequency IFNy+ response (D2 Dl) did not match
the hierarchy oftetramer staining (Dl D3).
We used PBMC taken 4 months after Dl vaccination to isolate cell lines. Two
HLA-A*1101-restricted cell lines which were cross-reactive for all variants were isolated
directly from limiting dilutions of peptide-stimulated bulk cultures (Figure 18B).
Table VII: Specificity of serotype cross-reactive dengue-specific CD8+ T cell clones
Donor Epitope Sequences HLA Secondar T cell
(primar restrction serotype clone
serotype) (In vitro
stimulation)
NS3 235-243 Dl:ALKGMPIRY HLA-B*62 JK IF8
donor D2:ALRGLPIRY JK62
D3:AMGLPIRY
D4:ALRGLPIRY
NS3 71- Dl:DVKLISY HLA-B*62 JK41
D2:SVKLISY
D3:DVKLISY
D4:DVRMISY
NS3527-536 D 1 :EARTFVEL HLA-B*07 llE
donor D2:EQRKTFVEL
D3 :ESRKTFVEL
D4:EQRKTFVEL
NS3 130- 140 Dl :GTSGSPNN HLA- 3C2
D2:GTSGSPIVR A*llOI 1 OC 11
D3 :GTSGSPII
a All the T cell clones except 3C2 were isolated following limiting dilution of bulk
cultures stimulated with peptides and screening for cytolytic activity against autologous
BLCLs pulsed with the same peptide used for stimulation.
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Simultaneous staining for IFNy and tetramer binding of the bulk cultures that were re-
stimulated for 6 hrs showed a heterogeneous population where there were twice as many
IFNy tetramer+ cells as those that only produced IFNy or only boundtetramer (Figure
19A). We attempted to isolate clones which could have such divergent effector profiles
by sorting for tetramer staining (Figure 19B). The limiting dilution of cells recovered
from the tetramer sort yielded one viable cell line 3C2 which was cross-reactive for all
variants by CTL but did not stain with the D2 tetramer (Figure 19C).
B. Selective induction of effector functions
One mechanism by which functional heterogeneity can be established within a
clonal population with a single specificity is the selective activation of some effector
functions. Clone JK62 was previously found to be cross-reactive for D2 and D3
(homologous) sequences but not the D4 varant ofNS3 71 peptide (Zivny, et aI. , 1999).
When we examined the cytokine responses by intracellular staining, we found that the
clone was not as effcient at producing IFNy, TNa,or MIP- IJ3 as compared to its ability
. to lyse cells (Figure 20). In response to D3 stimulation, 14% ofthe responding cells were
IFNy TNFot , only 4% were IFNtMIP- IJ3 , and around 2% of the total responding cells
produced a single cytokine. In contrast, heterologous stimulation with D2 sequence
induced poor IFNy, TNFa, and MIP- IJ3 despite activating robust cytotoxicity in this clone
indicating a segregation in the activation of various effector fuctions.
This selectivity in the induction of cytolytic vs cytokine functions was also seen
in clone lIE specific for the NS3 527 peptide (Figure 21A, 21B). While the heterologous
D3 variant induced ::60% lysis of autologous targets even at low peptide concentrations
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.c5% of cells were activated to produce IFNy or TNFa even at high peptide
concentrations. Stimulation with the homologous Dl peptide also induced diversity
within the cytokine response with less than halfthe IFNyproducing cells also producing
TNFa at any peptide concentration.
C. Hierarchy of functions and thresholds of activation:
We found that there was a clone-specific hierarchy in the activation of different
effector functions with higher concentrations of peptides required to elicit more than one
effector function. For clones 11E , JK41 , 1 OCll , and 3C2 , cytolysis was induced at lower
concentrations of both homologous peptide as well as the variant ligands as compared to
cytokine production (Figure 21 , 22). The 1 OC 11 clone had the same response profie to
all 3 sequences with cytolysis being elicited first, higher concentrations being required
for the production ofIFNy and MIP- l/J, and even the highest concentrations of peptide
failing to induce the production ofTNFa (Figure 22A).
In contrast, the 3C2 clone had a different profie to each of the three varants
(Figure 22B). Stimulation with the homologous D 1 sequence induced robust responses
only at concentrations of l/Lg/ml with cytolysis/degranulati responses in SO% of the
cells , MIP- l/J responses in 25%, and IFNy responses seen in .clO% ofthe cells. In
contrast, D2 peptide stimulation resulted in decreased degranulation but not cytolysis
and both IFNy and MIP- l/J production seen in .c 10% of the cells at the highest peptide
concentrations. The D3 varant was the most potent ligand for this clone since the
threshold for the activation of effector function was 3 logs lower as compared to the other
two sequences. While the induction of cytolysis required the mimimum concentration of
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peptide at O.OOI/lg/ml , degranulation was detected at O.OI/lg/ml, andlFNy and MIP-
l(J
had a similar dose response curves with the peak responses seen in 25- 40% of the cells at
::O. I/lg/ml.
D. Avidity differences as measured by tetramer staining:
We also examined the ability of peptide-stimulated T cells to bind tetramer in
order to analyze avidity of the cross-reactive T cells for their variant ligands as measured
byTCR down-regulation. Clone IF8 showed robust and equal cytolysis of cells pulsed
with 10/lg of all three variants but a hierarchy in IFNy responses with the highest
response of 82% seen for the D3 peptide, followed by Dl in 75% and then D2 in 54% of
the cells (Figure 23).However, tetramer staining showed that, while 100% of the cells
bound tetramer when left unstimulated, about 8% of cells stimulated with the D3 peptide
and producing IFNy showed decreased tetramer staining. Since such a down-regulation
was not seen with the other two peptides suggesting that the D3 sequence is a more
potent ligand than Dl and D2.
In another example , the lOCI 1 cell line isolated from Dl immune PBMC after 
vitro D2 stimulation showed strong cytolytic responses against all variants of the HLA-
A*1101 restricted NS3 130 epitope even at very low concentrations of peptide and very
low cytokine responses even at the highest concentrations of peptide (Figure 22A).
However, only 15% of the cell line bound tetramer when unstimulated
, and activation
with varous peptides caused a dose-dependent loss of tetramer staining at different rates
depending on the sequence (Figure 24). A higher percentage of cells secreted IFNy at
lower concentrations of D2 peptide than Dipeptide. In spite of this higher sensitivity to
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D2 in terms ofIFN"fproduction ipl was the more potent ligand ,since Dl activated cells
down-regulated their TCR-bound tetramer at l/Lg/ml while very little down-regulation
was seen in D2 activated cells' even at the highest concentration. In comparision with Dl
and D2 , the heterologous D3 peptide was the ligand to which the cell line had the
strongest avidity since even the lowest concentration ofD3 not only induced IFNy
secretion in half the responding population but also resulted in loss of tetramer staining in
all of these cells.
The D3 sequence proved to be a strong agonist in clone 3C2 , which also has the
same specificity. As seen in Figure 22B , this clone was proficient in degranulation and
cytolytic activity at the lowest peptide conceritration ofO.OOl/Lg/ml with higher
concentrations of l/Lg/ml ofthe D3 peptide required to elicit cytokine function in a third
of the responding population. Co-staining of functional markers with tetramer shows that
although 100% 0 f the clone bound tetramer when left unstimulated or stimulated with
less than l/Lg/ml ofDI or D2 peptide, cells stared to down-regulate tetramer-bound TCR
when stimulated with as little as O.OOI/Lg/ml (Figure 25A, 25B). The dose response to the
D3 sequence also showed that, although very few cells retained the ability to bind
tetramer at high peptide concentrations, not all tetramer+ cells which down-regulated
tetramer were able to degranulate or produce IFNy, and this population was in fact larger
than the numbers of cells in which the loss of tetramer staining was accompanied by one
or more effector function. This suggests that functional heterogeneity is even found
within a clonal population where all the cells have the same specificity but different
functional avidity for the ligand.
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E . Chapter Summary.
We examined the functional profies of 6 different clones isolated from 3 different
donors and specific for 4 different epitopes by stimulating them with varying
centrations of variant ligands and assaying for cytolysis and cytokine productio
. We
found that:
There was a segregation of effector function in response to some variants with
only cytolysis but low or absent cytokine production seen in some cases. There
was a further divergence of cytokine production within a clonal population with
some cells producing IFNy but not TNFa.
There were distinct thresholds of activation for. different effector functions with
degranulation and cytolysis requiring the lowest doses of antigen. There was a
further hierarchy within cytokine producing cells with increasing doses of peptide
required to elicit cytokines in the following order: MJP- l,B IFNy TNFa.
Down-regulation of tetramer in peptide dose response assays further defined
functional hierarchy.
Not all tetramer+ cells were functional
Cells responded functionally to variants despite being unable to bind
that varant tetramer.
Cells which were activated to undergo degranulation and cytokine
production down-modulated bound tetramer. A greater degree of
down-regulation was observed in cytokine-producing tetramer bound
cells than in degranulating tetramer-bound counterpars.
Cells lost their sensitivity to tetramer at high peptide concentrations
; -, : j!!
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Some cells which down-regulated tetramer appeared to be anergic
The diverse functional profiles and the existence of distinct activation thresholds
for different functions among these dengue-specific serotype cross-reactive clones have
significant implications for the mix ofcytokines, chemokines and cytotoxic T cells that
are generated during secondary immune response to heterologous infection. The absence
or reduction in the numbers of cells capable of a certain function such as IFNy production
could have a detrimental effect while contributing to protective immunity if the affected
response happens to be TNFaor MIP- ljJ. Antigen levels arealsn likely to dictate the
nature of the immune response since high peptide doses can elicit enhanced function or
result in functional anergy while low peptide doses skew the profie into a predominantly
cytolytic response.
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CHAPTER VI
DISCUSSION
The selective expansion of cross-reactive CD8+ T cells present in the antigen-
specific memory repertoire during the immune response toa heterologous viral infection
has been demonstrated in several models of viral infection. The response mediated by this
reamplified population is not necessarily protective in nature and, in fact, has been shown
in many situations to be immunopathologic (Selin, eta!., 1998; Chen, et aI. , 2001; Mon
et aI. , 2003; Haanen, et aI. , 1999; Klenerman and Zinkernagel, 1998). In these studies
immunopathology was associated with attrition of response, an alteration in the nature of
the effector functions of memory CD8+ T cells , or impaired viral clearance. In chronic
infections such as those caused by HIV and HBV, viral persistence has been attrbuted to
the emergence of viral escape mutations and T cell epitope varants which act as
antagonists of mti-viral CTL (Klenerman, et aI. , 1994; Bertoletti , et aI. , 1994). T cell
antagonism has also been shown to result in protective memory response and survival in
mice that would normally succumb to lethal immunopathology during co-infections with
an antagonist-APL expressing variant virus (Hunziker, et aI. , 2002).
Thus , differences in amino acid sequence between an original T cell epitope and
its variants can impact the functional outcome of a secondary infection. The four
serotypes of dengue virus do not share complete homology, leading to the possibility that
CD8+ T cell epitopes not conserved between serotypes will function as altered peptide
ligands during secondary infection and skew the memory response towards an
immunopathological outcome.
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This laboratory previously showed that a variant dengue peptide functioned as a
partial agonist ligand by stimulating robust cytolysis but weak proliferatio and IFNy
production (ZiVl1Y, et aI. , 1999). The goal of this thesis was to analyze the breadth and
complexity of cross-reactive T cell responses to dengue virus. We studied uhcloned T cell
populations by stimulating with natural variants from heterologous serotypes in order to
determine if stimulation with variant ligands would lead to altered profiles of effector
fuhction. We also examined dengue-specific serotype cross-reactive Tcell clones in order
to determine whether a polyfunctional response could exist within a clonal population
, to
understand how effector profies changed in response to peptide dose, and to examine the
changes in the functional hierarchy caused by dengue epitope varants which acted as
partial agonists.
A. Epitope identifcation strategy
Previously identified CD8+ T cell dengue epitopes were found to be restricted by
infrequently found HLA alleles such as HLA-B*62 and HLA-B*07 , and the frequencies
of cells specific for some of these epitopes were also very low. Our strategy therefore was
to identify new epitopes restricted by the HLA-A *0201 allele which is commonly found
in SE Asian populations. We used a computer algorithm to predict 9-mer peptides from
the sequences ofD2 and D3 serotypes that would best fit the HLA-A*02 binding motif
based on the half-life of dissociation ofpeptide-HLA complexes. The lists for each
serotype had several sequences in common, with the binding scores being identical in a
few cases and vastly different for most variants. However, the results from our screening
assays did not reflect these differences.
;yj
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The screening ofthese pe:ptides in IFNyELISPOT assays showed very weak
responses. Two possibilities that explain this result are that either the predicted peptides
with high scores were not actually produced by the processing machinery of the cells, or
that the primary immunization of the donor with the experimental vaccine induced cells
with low affnity to the epitopes. However, we were able to detect peptide-specific
responses in intracellular staining assays. It is possible that the two techniques differed in
their results because ofthe different peptide concentrations used (4f.g/ml peptide in
ELISPOT vs. 10ug/ml in ICS), the negative effect of cryopreservation- on the ability of
IFNy producing cells to form discernable spots in ELISPOT assays as reported by some
groups (Weinberg, et aI. , 2002), or due to the activation of peptide-specific cells that are
able to produce IFNy but not secrete it. Of the 25 peptides tested, 4 were eventually
identified as the strongest inducers of IFNy and 
TNFa response in intracellular staining
assays.
B. Quantitative and qualitative aspects of functional heterogeneity in uncloned
PBMC.
We observed high frequencies ofCD8+ T cells to all four HLA-A*02 restricted
epitopes in four vaccinated individuals. The total numbers of functionally active CD8+ T
cells specific for all four epitopes in each donor ranged from 0.7% to 4%, and the
frequencies of cells specific for each epitope as measured by intracellular IFNy secretion
ranged from 0. 12% to 0.64% of CD8+ T cells. This is comparable to frequencies of 0.02%
to 2.5% ofCD8+ cells specific for a HLA-A*II-restricteddengue NS3 epitope during the
acute phase of ilness and is higher than frequencies of 50 IFNy + cells/l 0 PBMC seen
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within 4 months of dengue infection in patients in Thailand and Vietnam
(Mongkolsapaya, et aI. , 2003; Mongkolsapaya et al. - 2005; Loke, et aI. , 2001).
Staining for IFNy, TNFa, and MIP-1,Bsimultaneously reveah:d that very few or
none of the cells produced all three cytokines, and that the majority of the responding
population produced only one of the three cytokines. Although this heterogeneity of
cytokine response in human PBMC to HIV and CMV epitopes has been reported
elsewhere (Appay, et aI. , 2000; Sandberg, et aI. , 2001; Betts, et aI. , 2006), none ofthese
studies examined the effect ofvariant peptide stimulation. We found that some variant
sequences induced higher frequencies ofTNFot cells and MJP- l,B+ than IFNy+ cells. One
explanation for this finding is that these cells contain preformed TNF-llrnA (Slifka, et
aI., 1999) and store MJP- 1,B in cytolytic granules that can be released even by low avidity
T cell interactions with pMHC (Wagner, et aI. , 1998; Zaitsova, et aI. , 2001), which would
lead to faster secretion kinetics for these two cytokines.
The detection of higher numbers of cells producing 
TNFa and MIP- l,B than IFN-
after peptide stimulation suggests that these cytokines might be a betterindicator of the
size ofthe epitope-specific population. It also would be interesting to analyze the
cytokine secretion patterns of these epitope-specific T cells in the context of tetramer
staining. This also could help answer the question of which cytokine accurately reflects
the actual numbers of epitope-specific cells.
The heterogeneous cytokine expression we observed could be significant in
determining the clinical outcome of the immune response. In addition to having antiviral
properties TNFa and MJP- l,B also are inflammatory cytokines (Dayton, et aI. , 1985;
Cocchi , et aI. , 1995). MIP- 1,B is a chemoattractant for bothmonocytes/macrophages and
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CD8+ T ' cells. The secretion of MlP.q P may result in immunopathology by two
mechanisms: the recruitmentofmonocytes to the site of infection might result in higher
viral load due to Ab';enhanced infection of these cells by virus , and the recruitment of
activated T cells during secondary infection might result in higher levels of inflammatory
cytokines. Thus, a situation where the secondary response in aD 1 immune donor is
dominated by cells specific for epitopes (NS4b 2423 and E493) whose heterologous
variants (D2 and D3) not only enhance the size ofthe response but also preferentially
activate MIP- l(3 or TNFa production, could result in increased disease severity (Figure 7;
top panel).
C. Potential influence of primary and secondary serotype on disease severity.
The size and pattern of responses to each epitope and its variant were unique to
each donor. However, within a donor, there were some similarties in the functional
profie to different peptides. The cytokine response in the D3 immunized donor was
characterized by low TNFa responses while in D2 immunized donor 3 , the response to all
stimulations was represented by all 7 sub-sets of cytokine producing cells (Figure 7;
panels in 2 and 3 row). Ifthese functional profies are found to be consistent for a
broader set of epitopes within each donor, the secondary response in these subjects would
likely be dominated by T cells with subdued inflammatory and enhanced anti-viral
properties.
Previous studies from our laboratory showed that dengue-specific CD4+ T cells
from immunized subjects showed the highest IFNy response to inactivated lysates ofVero
cells infected with the homologous serotype of dengue virus and to the homologous
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sequence of known CD4 epitopes identified so far (Mangada, et aI., 2004). The CD8+ T
ceil response to individual epitopes did not follow the same trend. A single variant of two
of the fourepitopes studied induced the highest totalcytokineresponse in all.four donors.
Also , the D3 sequence of the NS4b 2353 peptide induced cytokine responsesin/1.5% of
CD8+ T cells in three of the four donors. The immunogenicity of peptides D2 NS4a 2148
D3 NS4b 2423 , and D3 NS4b 2353 in these in vitro assays did not cOlTelate with their
algorithm-based predicted binding scores , which were low. However, it is possible that
these three sequences have the highest immunogenicity 
in vivo since the binding scores
do not take into account the half-life of dissociation between pMHC and theTCR
complex.
Some epidemiological studies have associated dengue 2 and dengue 3 infections
with greater disease severity (Sangkawibha, et aI. , 1984; Endy, et aI. , 2002; Leitmeyer, et
aI. , 1999). In our studies, when the total cytokine responses to all four epitopes of each
serotype were compared (Fig. 6), peptides of the D2 and D3 serotypesinduced the
highest responses in all 4 donors. A majority of our long-term T cell clones also showed a
higher avidity to the D3 sequence of their epitopes. It is not known whether there are any
molecular strctures or other viral factors that determine D3 prevalence and support its
association with severe outbreaks as compared to other serotypes (Nisalak, et aI. , 2003).
A recent study which modeled the effects of ADE on the ability of co-circulating
serotypes to survive and evolve showed that serotypes that undergo enhancement have a
competitive advantage and are able to persist within an endemic population (Cummings
et aI., 2005). It is possible that the D3 serotype, which is known to undergo ADE and co-
circulate, has escaped this selection pressure by mutating antigenic epitopes. Although
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responses to a broader group ofepitopes wouldneedtobe examined in more subjects in
order to make definitive conclusions about the immunodominance ofD3 epitopes , these
preliminary findings are consistent with the hypothesis that secondary infectiDn with these
two serotypes might result in enhanced cytokine response and result in iIIunopathology
in HLA-A *02+ individuals.
D. Cross-reactivity and functional heterogeneity in short-term T cell cultures.
We developed a novel method to directly demonstrate serotype cross-:reactivity
among epitope-specific cells in CFSE-stained bulk cultures. These were set up by in vitro
stimulation with the homologous peptide and sequentially stimulated after expansion by
variant peptides. Proliferating cells underwent 8 divisions in about 10 days and the
serotype-cross-reactive cells were identified by their CFSEIOWIFNy profie when re-
stimulated with heterologous peptide (Figure 8). These cross-reactive cells were
functionally diverse since there a significant fraction (16% - 32%) of these proliferated
cells secreted TNFa but not MIP- l(3, in contrast to the secretion of all three cytokines by
100% of homologous peptide-restimulated cells.
There was also a substantial portion of CFSE low cells which did not produce any
ofthe three cytokines following either homologous or varant peptide stimulation or show
tetramer staining (Figures 8 , 10 , 11). It is possible that these cells represent non-epitope
specific cells that have undergone cytokine-stimulated, antigen-independent division.
There was also a population of cells which had undergone 0-5 rounds of cell division that
produced IFNy following homologous peptide re-stimulation but did not bind the
homologous tetramer. There is some evidence of an association between cell division and
109
the acquisition of effector functions where the cells that undergo the most proliferati
are the ones that are most proficient at secreting IFNy (Gudmundsdottir, et aI., 1999). In
that study, the authors examined the cOli-elation between the degree of Clonal expansion
and secretion of different cytokines in OVA-specific CD4+ T cells from transgenic mice
and found that the division cycle not only affected the absolute numbers of cytokine
producing cells but also the ability to secrete cytokines at the single cell level. Although
we did not pursue the mechanisms which influence heterogeneity in the expanded
populations , it is possible that cytokine + cells within the CFSEmid-
high population are low
affnity cells that have not completed their full program of cell division and hence have
an incomplete activation profile.
E. Intraclonal heterogeneity and functional avidity of serotype cross-reactive T cell
clones.
We simultaneously measured multiple effector functions of serotype cross-
reactive T cell clones over a range of peptide doses to characterize the functional avidities
ofthese clones for their cognate vs varant ligands. The stimulation of cross-reactive
clones with variant ligands revealed an activation threshold difference in the
requirements for the activation of cytolysis vs the production of various cytokines. Some
variant ligands induced CTL responses even at low peptide concentrations but only
induced cytokine production at high peptide concentrations or failed to induce any
cytokine function. Other variants induced CTL at peptide concentrations higher than that
required for cognate ligands in clones that showed very poor cytokine production. Thus
there was a hierarchy in the induction of the two functions with cytolysis requiring less
ligand concentration and having a lower activation threshold than cytokine production.
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Our observation that all of our clones retaineytolytic ability even in the absence
of other effector functions merits further discussion. For the successful elimination of
dengue virus without the immunopathological after-effects, such a dichotomy b tween
these two functions might be an advantage. Cytolysis and IFNy production are known to
have different signaling thresholds with lower peptide concentrations being required to
elicit lytic functions from a T cell clone in vitro (Valitutti , et aI. , 1996). If this is also the
case in vivo then dengue infections which result in low antigen load will be more easily
cleared without the activation ofa cytokine cascade that might result in DHF. The
recovery of a large number of such clones as opposed to those with the reverse phenotype
(more cytokine, less cytolysis) might either be a consequence of selecting for antigen-
specific populations via CTL-based limiting dilution assays or may simply reflect the
persistence of these "protective" clones within the memory PBMC population.
Other studies which examined murine flu-specific CD8+ responses (La Gruta, et
aI. , 2004), human flu-specific CD8+ T cell clones (Valitutti, et aI., 1996), or HIV -specific
human CD8+ T cell clones (Douek, et aI. , 2002) showed that there was a difference in the
hierarchy of epitope-specific cytokine production between the primary and secondary
response to the same epitope and that the concentration of peptide required for the
induction of cytolysis IFNy proliferation. However, the dependence of functional
hierarchy on the level ofT cell activation by variant ligands that we observed in our
studies has only been previously reported in human CD4+ T cell clones in, the context 
autoreactivityand activation by self-peptides and their synthetic variants (Itoh and
Germain, 1997. , Hemmer, et aI. , 1998; Itoh, et aI. , 1999).
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A recent study which examinedcytokine hierarchies in human CD8+ T cell clones
specific for a flu epitope and an EBV epitope showed a pattern ofMIP- ltPIFNy::TNFa
(higher percentage of cells producing MIP- , followed by the others) response in clones
cross-reactive for both epitopesbut not in clones with a specificity for only one of the
epitopes (Clute SC, 2005). In our studies , we observed that a similar hierarchy of
cytokine response in serotype cross-reactive clones, which was both clone- and peptide-
specific. However, we also found that the pattern ofMIP- l/pIFNy::TNFa seen in
response to homologous peptide stimulation was altered following variant stimulation at
different peptide doses. For example , the proportion of cells producing MIP- and IFNy
were identical. In other words, as variant ligand concentration increased, the ratios of
cells producing the three cytokines changed in a clone-'specific manner.
It has also been shown that the level ofTCR down-modulation (an indicator of
TCR engagement) has a direct correlation with the activation ofT cell responses, since
ligands that are more efficient at inducing functional responses induce TCR down-
regulation more robustly than weaker ligands (Bachmann, et aI. , 1997; Hemmer, et aI.
1998; Itoh, et aI. , 1999). We also observed this association in two dengue-specific T cell
clones. The D3 variant to which both clones had the highest functional avidity induced
the most profound loss of tetramer staining (Figures 24, 25). In contrast, the D 1 and D2
ligands, which induced robust CTL but no cytokine response at high peptide
concentrations , showed more modest decreases in tetramer binding ability. Interestingly,
when we compared tetramer down-regulation between populations of cells which were
IFNy + versus CD 1 07 a + , we found that there were more CD 1 07 a + cells which had down-
regulated tetramer as compared to IFNy + cells at higher peptide concentrations (Figure
112
27b). Since JFNy production has been shown to be associated with significantly more
ligand-induced TCR down-modulation than cytotoxicity (Valitutti, et aI. , 1996), we
interpreted these results to mean that cells with different functional avidities could be
found ,even within an activated clonal population of cells.
Interestingly, there was also a sizeable population of cells which had down-
regulated tetramer but did not express an effector function. These cells may be
temporarily anergized or may represent a distinct population of cells with effector
functions other than the secretion of the three cytokines studied. We speculate that the
former possibility is likely since a previous study showed that 
in vitro resting" of CD4 T
cells which had down-regulated their TCR VI) chains but failed to produce IFNy after
sorting reversed the unresponsiveness to TCR engagement (Itoh and Germain. , 1997).
F. Summary of in vitro results.
Overall, these in vitro data imply that (i) the cross-reactive T cell population that
expands during secondary dengue infection will be influenced by antigen load and the
functional avidities of the cross-reactive cells for the varant epitope. (ii) The altered TCR
activation by varant epitopes during secondary infection can result in a polyfunctional T
cell response. (iii) The relative frequencies of these T cell sub-sets wil dictate the type
and level of cytokines and chemokines produced and thus influence disease severity. 
We were unable to compare these patterns of functional heterogeneity seen during
in vitro analysis of secondary response in vaccinated individuals with the response seen
in infected individuals due to limited numbers of patient samples available and the
difficulty of maintaining the viability of cells obtained during acute ilness in culture. We
, I
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therefore restricted our study to the analysis of phenotypic heterogeneity in acute disease
vs convalescence in individuals with DF and DHF.
G. Alterations in the kinetics and phenotype of dengue-specific immune ' response
during acute infection leading to severe disease.
The detection of high levels of pro inflammatory cytokines and other markers of
immune activation during clinical illness in DHF clearly argues for a role for dengue-
specific T cells in disease mediation at the time of defervescence. Hence it is crucial to
document the kinetics of T cell expansion during secondary response and understand how
the onset of cross-reactive T cell function correlates with disease phenotype. We
analyzed the response specific to the HLA-B*07 restricted NS3 222-231 epitope in 5
patients with DF and 5 with DHF. We found that the frequencies oftetramer+ CD8
+ T
cells were not only significantly higher in those with more severe disease, but that they
were detected as early as 5 days prior to defervescence. This is in contrast to other studies
which measured the frequencies of epitope-specific CD8+ T cells throughout the acute
phase and pegged the peak ofthe T cell response at 2 weeks after defervescence
(Mongkolsapaya, et aI., 2003; Mongkolsapaya, et aI. , 2005). The findings in those reports
are at odds with the kinetics of disease onset and progression, since pathologic symptoms
in secondary dengue-infected patients with DHF occur at the end of the viremic phase
with the severity of illness coinciding with a sudden drop in viral load (Libraty, et aI.
2002). While our study as well as the previous studies included epitopes which are well
conserved between serotypes , it is possible that the kinetics of response are specific both
to the epitope in question as well the level of homology between its variants.
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While the range oftetfamer+ T cell frequencies obserVed in our study is
comparable to or higher than those seen by Mongolsapaya et al.(2003, 2005) and those
reported in other studies during acute dengue illness (Loke, et aI. , 2001), massive and
early changes in the size of theepitope..specific response seen in some of the DHF
patients are novel findings. In the DHF cases where early bleeds were unavailable, the
frequencies of tetramet cells ranged up to 1 %-S % of circulating CD8+ T cells even in
the acute stage. While it is impossible to clearly identify the peak response in these
donors , the presence of such high tetramer + populations in circulation 1-5 days before
antigen clearance suggests that these cells may be responsible for initiating the
immunopathology seen during secondary DHF.
H. Alterations in epitope-specifc T cell phenotype after secondary infection.
Activation of memory cells during a recall response is accompanied by changes in
the surface expression of various markers which track their differentiation into effector T
cells. In DHF patients, these cells displayed a late activated phenotype as shown by CD38
expression on ::80% of the tetramer+ population while remaining high in CD69
expression. In addition, we found that DHF patients had higher frequencies of
CD69 tetramer+ cells as compared to DF patients. This difference in the activation profie
of CDS+ T cells was seen in a previous study which compared total CD8+ responses in
DF and DHF patients (Green, et aI. , 1999). Our results indicate that there is earlier
activation of dengue-specific T cells in those who develop severe disease.
The tetramer+ populations in DF vs DHF patients also varied in the expression of
homing receptors. Interestingly, in some donors , only a fraction of the tetramer+ CD3S
cells down-regulated CCR 7. Since the CCR phenotype is a hallmark of effector
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memory T cells as proposed by the central/effector memory hypothesis (Sallusto, et aI.,
1999), it is possible that there is. a functional heterogeneity among the tetramer 
population. Other groups have reported that only the CD38 CCRT subsets are proficient
in proliferation and in the production of IFNy and TNFa during anti-EBV and anti-
pafVovirus B 19 responses (Hislop, et aI. , 2001; Isa, et aI. , 2005). CCR7 staining was also
higher in the convalescent samples as compared to the corresponding acute samples in
the DF donors. But tetramer+ cells detected during convalescence in DHF patients
unexpectedly showed little CCR7 expression. This suggests that there may be sustained
immunologic effects in the dengue-specific memory T cell population months after
recovery from DHF and the prevalence of effector memory subsets capable of cytokine
production may contribute to disease exacerbation.
Earlier in vitro studies had showed that T cells in the acute phase of the disease
were impaired in proliferation, and that this was due to functional defects in the APC
(Mathew, et at , 1999). Since DCs and monocytes, which are targets ofDV infection, can
suppress T cell activation and proliferation via their expression ofPD-Ll (programmed
death receptor ligand 1), we were interested in seeing whether dengue-specific T cells
would express the PD- l receptor for this ligand. We have now shown for the first time
that PD- 1 is expressed on a majority of the tetramer+ cells during acute illness. This is the
first documentation of PD- l expression on T cells during acute infection in humans. We
also observed PD- 1 expression on a large number of tetrame( cells which may be either
other dengue-specific or bystander cells. Although the kinetics of PD- 1 expression durng
acute ilness are unkown, and the mechanisms and the extent to which PD- l signaling
suppresses T cell function are still unclear, studies ofHIV infection showed that PD-
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expression leads to decrea:sedIL 2 and TNFci production while not affecting the
production of IFNy (Petrovas , et aI. , 2006; Trautman, et at , 2006). It is therefore
conceivable that the dengue-specific T cells that have undergone massive expansion. after
initial antigen contact at the start of the response to secondary dengue infection are
impaired in some or all of their effector functions thus producing a functionally'
heterogeneous T cell response which may lead to enhanced immunopathology.
I. Serotype cross-reactivity during secondary dengue infection.
As discussed previously, ' original antigenic sin ' has been proposed as mechanism
which contributes to DHF immunopathology due to the dominance ofT cells which have
low avidity for the secondary serotype and are therefore ineffcient at viral clearance
(Mongkolsapaya, et aI. , 2003). We also observed this pattern of increased avidity for the
primary serotype since a higher proportion of dengue-specific T cells bound to the variant
tetramer. However, we also found that the ratio ofT cells with different avidities for their
cognate and varant ligands was not static. In other words, the population of epitope-
specific cells that was undergoing expansion during acute infection was not always
dominated by low avidity cells but underwent day-to-day changes. Although we have not
compared the effector functions between these two populations, we speculate that these
high avidity T cells can also contribute to DHF because oftheir capacity to not just
effciently lyse virus-infected cells but because their expanded numbers wil have
resulted in a highly inflammatory environment.
J. Models of serotype cross-reactive T cell mediation of secondary immune response
in heterologous dengue infection
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Based on ex vivo analyses of phenotypic and funct.ional cross-reactive CDS+ T
cell responses from dengue-infected and vaccinated individuals, this thesis strengthens
the view that DHF immunopathology is a consequence of an early and increased immune
response and that the T cell response to secondary dengue infection is mediated by a
heterogeneous population of memory CDST cells that have undergone a robust program
of expansion during acute infection (Figure 26A, B). The phenotypic heterogeneity,
. expression ofPD- , and alterations in the sensitivity to tetramer binding imply that the
virus-specific population includes functionally diverse sub-sets of cells which could be
activated to induce selective responses depending on the antigen load and serotype. The
presence of such a functional hierarchy within a serotype cross-reactive epitope-specific
population implies that a secondary infection with a serotype encoding epitope varants
will change the relative ratios of different functional sub-sets within the expanded
memory pool and immunopathology may result if this qualitative alteration in the
secondary immune response is primarily mediated by inflamatory sub-sets (Figue 26B
C).
The ultimate goal of these studies is to establish a direct correlation between a
particular profie of cross-reactive T cell response and disease state in order to design
vaccines that are capable of manipulating T cell effector function to achieve immune
protection rather than immunopathology. The diverse and unkown histories of viral
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infection and the private specificities bfTcell repertoires may make this a diffcult task
(Kim, et aI. , 2005). Nevertheless , examination ora broader spectrum ofT cell effector
functions in dengue immune subjects who have varied clinical manifestations of dengue
disease should further our understanding of secondary immune responses against
heterologous dengue infection. This, in turn, will hopefully facilitate the development of
a vaccine strategy that would provide immunity against all 4 dengue serotypes without
inducing immunopathologic cross-reactive responses.
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